id	sid	tid	token	lemma	pos
work_4jheoe6s5jbc5lxgowinku6jgi	1	1	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	1	2	High	high	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	1	3	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	1	4	Resolution	resolution	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	5	Hla	Hla	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	6	Match	Match	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	7	Rate	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	8	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	1	9	The	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	1	10	Impact	Impact	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	11	Of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	1	12	Race	Race	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	13	S170	S170	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	14	Oral	Oral	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	15	Presentations	Presentations	NNPS
work_4jheoe6s5jbc5lxgowinku6jgi	1	16	Conclusion	Conclusion	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	17	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	1	18	These	these	DT
work_4jheoe6s5jbc5lxgowinku6jgi	1	19	demonstrated	demonstrate	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	1	20	that	that	IN
work_4jheoe6s5jbc5lxgowinku6jgi	1	21	safety	safety	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	22	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	1	23	feasibility	feasibility	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	24	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	1	25	third	third	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	1	26	party	party	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	27	UCB	UCB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	28	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	1	29	derived	derive	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	1	30	MSCs	mscs	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	31	use	use	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	32	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	1	33	co	co	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	34	-	-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	35	infusion	infusion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	36	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	1	37	UCB	UCB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	38	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	1	39	derived	derive	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	1	40	MSCs	msc	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	1	41	can	can	MD
work_4jheoe6s5jbc5lxgowinku6jgi	1	42	overcome	overcome	VB
work_4jheoe6s5jbc5lxgowinku6jgi	1	43	graft	graft	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	44	dysfunction	dysfunction	NN
work_4jheoe6s5jbc5lxgowinku6jgi	1	45	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	1	46	UCBT	UCBT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	1	47	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	2	1	HISTOCOMPATIBILITY	HISTOCOMPATIBILITY	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	2	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	2	3	ALTERNATIVE	alternative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	2	4	STEM	stem	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	2	5	CELL	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	6	SOURCES	sources	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	7	49	49	CD
work_4jheoe6s5jbc5lxgowinku6jgi	2	8	CORD	cord	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	9	BLOOD	blood	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	10	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	11	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	12	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	13	APGAR	APGAR	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	2	14	SCORE	score	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	15	IS	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	2	16	PREDICTIVE	predictive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	2	17	OF	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	2	18	NEUTROPHIL	NEUTROPHIL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	19	ENGRAFTMENT	ENGRAFTMENT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	20	AND	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	2	21	GRAFT	GRAFT	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	2	22	FAILURE	failure	IN
work_4jheoe6s5jbc5lxgowinku6jgi	2	23	PROBABILITIES	probability	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	2	24	FOR	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	2	25	PLASMA	PLASMA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	26	DEPLETED	deplete	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	2	27	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	2	28	REDUCED	REDUCED	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	29	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	30	PRODUCTS	PRODUCTS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	31	Chow	Chow	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	32	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	33	R.1,2	R.1,2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	34	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	35	Wang	Wang	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	36	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	37	B.C.1	B.C.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	38	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	39	Chou	Chou	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	40	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	41	D.1	D.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	42	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	43	Chow	Chow	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	44	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	45	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	46	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	47	Wu	Wu	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	48	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	49	T.1	T.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	50	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	51	Kang	Kang	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	52	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	53	J.2	J.2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	54	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	55	Petz	Petz	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	56	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	57	L.D.1	L.D.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	58	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	59	Kurtzberg	Kurtzberg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	60	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	61	J.3	J.3	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	62	1StemCyte	1stemcyte	CD
work_4jheoe6s5jbc5lxgowinku6jgi	2	63	International	International	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	64	Cord	Cord	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	65	Blood	Blood	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	66	Center	Center	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	67	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	68	Covina	Covina	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	69	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	70	CA	CA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	71	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	2	72	2StemCyte	2stemcyte	CD
work_4jheoe6s5jbc5lxgowinku6jgi	2	73	Taiwan	Taiwan	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	74	National	National	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	75	Cord	Cord	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	76	Blood	Blood	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	77	Center	Center	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	78	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	79	Linkou	Linkou	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	80	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	81	Taiwan	Taiwan	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	82	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	2	83	3Duke	3Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	84	University	University	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	85	Medical	Medical	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	86	Center	Center	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	87	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	88	Durham	Durham	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	89	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	90	NC	NC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	91	Nucleated	Nucleated	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	92	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	93	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	94	NC	NC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	95	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	96	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	97	CD341	CD341	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	98	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	99	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	100	CD34	CD34	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	101	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	102	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	103	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	2	104	colony	colony	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	105	forming	forming	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	106	unit	unit	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	107	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	108	CFU	CFU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	109	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	2	110	doses	dose	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	2	111	have	have	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	2	112	been	be	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	2	113	proposed	propose	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	2	114	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	2	115	measure	measure	VB
work_4jheoe6s5jbc5lxgowinku6jgi	2	116	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	2	117	potency	potency	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	118	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	2	119	important	important	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	2	120	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	2	121	engraftment	engraftment	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	2	122	potential	potential	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	2	123	prediction	prediction	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	124	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	2	125	transplantation	transplantation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	126	product	product	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	127	selec-	selec-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	128	tion	tion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	129	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	2	130	ThoughTNCiswidelyusedforCBselection	thoughtnciswidelyusedforcbselection	CD
work_4jheoe6s5jbc5lxgowinku6jgi	2	131	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	2	132	itspredictivevalueis	itspredictivevalueis	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	133	not	not	RB
work_4jheoe6s5jbc5lxgowinku6jgi	2	134	as	as	RB
work_4jheoe6s5jbc5lxgowinku6jgi	2	135	robust	robust	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	2	136	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	2	137	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	2	138	progenitor	progenitor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	139	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	2	140	measurements	measurement	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	2	141	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	3	1	CFU	CFU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	3	2	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	3	3	CD34	CD34	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	3	4	suf-	suf-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	3	5	fer	fer	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	3	6	from	from	IN
work_4jheoe6s5jbc5lxgowinku6jgi	3	7	high	high	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	3	8	inter	inter	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	3	9	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	3	10	laboratory	laboratory	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	3	11	coefficient	coefficient	NN
work_4jheoe6s5jbc5lxgowinku6jgi	3	12	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	3	13	variance	variance	NN
work_4jheoe6s5jbc5lxgowinku6jgi	3	14	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	3	15	CV	CV	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	3	16	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	3	17	-	-	:
work_4jheoe6s5jbc5lxgowinku6jgi	3	18	decreasing	decrease	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	3	19	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	3	20	clinical	clinical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	3	21	utility	utility	NN
work_4jheoe6s5jbc5lxgowinku6jgi	3	22	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	3	23	potency	potency	NN
work_4jheoe6s5jbc5lxgowinku6jgi	3	24	measures	measure	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	3	25	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	4	1	Recently	recently	RB
work_4jheoe6s5jbc5lxgowinku6jgi	4	2	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	4	3	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	4	4	Duke	Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	5	Group	Group	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	6	pro-	pro-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	7	posed	pose	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	4	8	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	4	9	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	10	APGAR	apgar	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	11	scoring	score	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	4	12	system	system	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	13	composed	compose	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	4	14	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	4	15	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	16	a	a	LS
work_4jheoe6s5jbc5lxgowinku6jgi	4	17	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	18	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	4	19	Pre	Pre	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	20	-	-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	21	Cryopre-	Cryopre-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	22	served	serve	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	4	23	Score	Score	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	24	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	25	PCS	PCS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	26	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	27	reflecting	reflect	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	4	28	pre	pre	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	4	29	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	4	30	freeze	freeze	VB
work_4jheoe6s5jbc5lxgowinku6jgi	4	31	CFU	CFU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	32	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	4	33	CD34	CD34	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	34	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	4	35	NC	NC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	36	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	4	37	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	4	38	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	39	collected	collect	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	4	40	volume	volume	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	41	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	4	42	as	as	RB
work_4jheoe6s5jbc5lxgowinku6jgi	4	43	well	well	RB
work_4jheoe6s5jbc5lxgowinku6jgi	4	44	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	4	45	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	4	46	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	47	b	b	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	48	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	49	Composite	Composite	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	50	Score	Score	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	51	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	52	CS	CS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	53	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	4	54	which	which	WDT
work_4jheoe6s5jbc5lxgowinku6jgi	4	55	combines	combine	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	4	56	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	4	57	PCS	PCS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	58	score	score	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	59	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	4	60	post	post	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	4	61	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	4	62	thaw	thaw	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	4	63	NC	NC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	64	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	4	65	CD34	CD34	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	66	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	4	67	CFU	CFU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	4	68	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	4	69	mononuclear	mononuclear	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	70	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	71	dose	dose	NN
work_4jheoe6s5jbc5lxgowinku6jgi	4	72	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	5	1	Based	base	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	5	2	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	5	3	single	single	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	5	4	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	5	5	myeloablative	myeloablative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	5	6	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	5	7	first	first	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	5	8	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	5	9	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	5	10	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	5	11	transplants	transplant	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	5	12	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	5	13	largely	largely	RB
work_4jheoe6s5jbc5lxgowinku6jgi	5	14	pediatric	pediatric	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	5	15	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	5	16	performed	perform	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	5	17	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	5	18	Duke	Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	5	19	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	5	20	using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	5	21	mostly	mostly	RB
work_4jheoe6s5jbc5lxgowinku6jgi	5	22	red	red	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	5	23	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	5	24	reduced	reduce	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	5	25	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	5	26	RCR	RCR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	5	27	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	5	28	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	5	29	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	5	30	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	5	31	PCS	PCS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	5	32	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	5	33	CS	CS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	5	34	scores	score	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	5	35	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	5	36	shown	show	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	5	37	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	5	38	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	5	39	predictive	predictive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	5	40	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	5	41	graft	graft	NN
work_4jheoe6s5jbc5lxgowinku6jgi	5	42	failure	failure	NN
work_4jheoe6s5jbc5lxgowinku6jgi	5	43	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	5	44	neutrophil	neutrophil	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	5	45	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	5	46	platelet	platelet	NN
work_4jheoe6s5jbc5lxgowinku6jgi	5	47	engraftment	engraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	5	48	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	6	1	With	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	6	2	CIBMTR-	CIBMTR-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	3	auditedoutcomedataoftransplantedCBproductsfromamulti	auditedoutcomedataoftransplantedcbproductsfromamulti	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	6	4	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	6	5	national	national	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	6	CBbank	CBbank	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	7	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	6	8	wesought	wesought	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	6	9	tovalidatetheCBAPGARsystemon	tovalidatetheCBAPGARsystemon	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	10	apatient	apatient	NN
work_4jheoe6s5jbc5lxgowinku6jgi	6	11	pop-	pop-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	6	12	ulationwithmostlyadults	ulationwithmostlyadult	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	6	13	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	6	14	heavyrepresentationofminorityandinterna-	heavyrepresentationofminorityandinterna-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	15	tional	tional	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	6	16	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	6	17	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	6	18	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	6	19	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	6	20	both	both	DT
work_4jheoe6s5jbc5lxgowinku6jgi	6	21	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	22	transplants	transplant	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	6	23	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	6	24	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	6	25	all	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	6	26	transplants	transplant	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	6	27	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	6	28	All	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	6	29	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	6	30	using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	6	31	plasma	plasma	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	32	depleted	deplete	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	6	33	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	6	34	reduced	reduce	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	6	35	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	6	36	PDR	PDR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	37	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	6	38	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	6	39	products	product	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	6	40	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	7	1	The	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	7	2	PCS	PCS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	3	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	7	4	CS	CS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	5	table	table	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	6	below	below	RB
work_4jheoe6s5jbc5lxgowinku6jgi	7	7	shows	show	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	7	8	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	7	9	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	10	42	42	CD
work_4jheoe6s5jbc5lxgowinku6jgi	7	11	neutrophil	neutrophil	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	12	engraftment	engraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	13	cumulative	cumulative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	7	14	inci-	inci-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	15	dence	dence	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	16	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	7	17	ANC500	ANC500	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	18	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	7	19	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	7	20	graft	graft	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	21	failure	failure	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	22	probability	probability	NN
work_4jheoe6s5jbc5lxgowinku6jgi	7	23	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	7	24	GF	GF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	25	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	7	26	comparisons	comparison	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	7	27	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	7	28	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	7	29	Duke	Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	30	data	datum	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	7	31	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	7	32	PDR	PDR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	33	transplants	transplant	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	7	34	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	7	35	both	both	DT
work_4jheoe6s5jbc5lxgowinku6jgi	7	36	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	7	37	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	7	38	All	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	7	39	transplants	transplant	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	7	40	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	8	1	For	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	8	2	each	each	DT
work_4jheoe6s5jbc5lxgowinku6jgi	8	3	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	8	4	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	8	5	PCS	PCS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	6	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	8	7	CS	CS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	8	strata	strata	NN
work_4jheoe6s5jbc5lxgowinku6jgi	8	9	compared	compare	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	8	10	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	8	11	ANC500	ANC500	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	12	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	8	13	GF	GF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	14	ap-	ap-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	15	peared	peare	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	8	16	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	8	17	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	8	18	similar	similar	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	8	19	among	among	IN
work_4jheoe6s5jbc5lxgowinku6jgi	8	20	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	8	21	Duke	Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	22	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	23	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	8	24	StemCyte	StemCyte	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	25	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	8	26	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	8	27	All	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	8	28	co-	co-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	8	29	horts	hort	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	8	30	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	9	1	We	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	9	2	conclude	conclude	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	9	3	that	that	IN
work_4jheoe6s5jbc5lxgowinku6jgi	9	4	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	9	5	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	6	APGAR	APGAR	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	9	7	score	score	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	8	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	9	9	especially	especially	RB
work_4jheoe6s5jbc5lxgowinku6jgi	9	10	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	9	11	PCS	PCS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	12	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	9	13	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	9	14	an	an	DT
work_4jheoe6s5jbc5lxgowinku6jgi	9	15	easy	easy	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	9	16	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	9	17	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	9	18	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	9	19	use	use	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	20	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	9	21	reproducible	reproducible	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	9	22	potency	potency	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	23	measurement	measurement	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	24	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	9	25	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	26	selection	selection	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	27	by	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	9	28	transplant	transplant	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	29	centers	center	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	9	30	that	that	WDT
work_4jheoe6s5jbc5lxgowinku6jgi	9	31	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	9	32	highly	highly	RB
work_4jheoe6s5jbc5lxgowinku6jgi	9	33	predictive	predictive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	9	34	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	9	35	ANC500	ANC500	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	36	engraftment	engraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	37	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	9	38	GF	GF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	39	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	9	40	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	9	41	1	1	LS
work_4jheoe6s5jbc5lxgowinku6jgi	9	42	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	9	43	RCR	RCR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	44	as	as	RB
work_4jheoe6s5jbc5lxgowinku6jgi	9	45	well	well	RB
work_4jheoe6s5jbc5lxgowinku6jgi	9	46	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	9	47	PDR	PDR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	48	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	9	49	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	9	50	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	9	51	2	2	LS
work_4jheoe6s5jbc5lxgowinku6jgi	9	52	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	9	53	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	9	54	mostly	mostly	RB
work_4jheoe6s5jbc5lxgowinku6jgi	9	55	pediatric	pediatric	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	9	56	patient	patient	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	9	57	pop-	pop-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	58	ulationaswellasformixedpopulationsofadultsandchildren	ulationaswellasformixedpopulationsofadultsandchildren	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	9	59	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	9	60	and(3)for	and(3)for	CC
work_4jheoe6s5jbc5lxgowinku6jgi	9	61	minority	minority	NN
work_4jheoe6s5jbc5lxgowinku6jgi	9	62	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	9	63	international	international	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	9	64	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	9	65	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	10	1	Whether	whether	IN
work_4jheoe6s5jbc5lxgowinku6jgi	10	2	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	10	3	methodcanbeapplied	methodcanbeapplie	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	10	4	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	10	5	double	double	VB
work_4jheoe6s5jbc5lxgowinku6jgi	10	6	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	10	7	non	non	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	8	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	9	myeloablative	myeloablative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	10	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	10	11	repeat	repeat	NN
work_4jheoe6s5jbc5lxgowinku6jgi	10	12	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	13	transplants	transplant	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	10	14	remains	remain	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	10	15	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	10	16	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	10	17	seen	see	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	10	18	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	10	19	Lastly	lastly	RB
work_4jheoe6s5jbc5lxgowinku6jgi	10	20	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	10	21	forthesamePCSorCSstrata	forthesamePCSorCSstrata	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	22	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	10	23	PDRCBappeartohavesim-	PDRCBappeartohavesim-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	24	ilar	ilar	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	25	engraftment	engraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	10	26	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	10	27	GF	GF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	28	probabilities	probability	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	10	29	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	10	30	RCR	RCR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	31	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	32	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	10	33	therefore	therefore	RB
work_4jheoe6s5jbc5lxgowinku6jgi	10	34	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	10	35	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	10	36	Duke	Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	37	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	38	APGAR	APGAR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	39	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	10	40	applicable	applicable	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	41	to	to	IN
work_4jheoe6s5jbc5lxgowinku6jgi	10	42	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	43	products	product	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	10	44	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	10	45	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	10	46	without	without	IN
work_4jheoe6s5jbc5lxgowinku6jgi	10	47	RBC	RBC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	48	reduc-	reduc-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	49	tionandreflectspotencyofCBproductsprocessedandstoredbyvarious	tionandreflectspotencyofcbproductsprocessedandstoredbyvarious	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	50	methods	method	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	10	51	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	10	52	different	different	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	10	53	CB	CB	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	10	54	banks	bank	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	10	55	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	11	1	Table	table	NN
work_4jheoe6s5jbc5lxgowinku6jgi	11	2	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	11	3	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	12	1	ANC	ANC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	2	500	500	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	3	Engraftment	Engraftment	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	4	Cumulative	Cumulative	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	5	Incidence	Incidence	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	6	&	&	CC
work_4jheoe6s5jbc5lxgowinku6jgi	12	7	Graft	Graft	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	8	Failure	Failure	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	9	Probabilities	Probabilities	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	10	ANC	ANC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	11	500	500	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	12	Duke	Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	13	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	14	PDR	PDR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	15	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	16	PDR	PDR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	17	All	All	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	18	PCS$7.75	pcs$7.75	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	19	93	93	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	20	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	21	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	22	86	86	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	23	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	24	100	100	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	25	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	26	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	27	100±18	100±18	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	28	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	29	83±19	83±19	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	30	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	31	PCS<7.75	pcs<7.75	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	32	75	75	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	33	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	34	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	35	69	69	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	36	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	37	81	81	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	38	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	39	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	40	78±9	78±9	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	41	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	42	76±4	76±4	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	43	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	44	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	45	2.44	2.44	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	46	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	47	1.78	1.78	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	48	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	49	3.59	3.59	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	50	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	51	2.43	2.43	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	52	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	53	0.85	0.85	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	54	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	55	6.95	6.95	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	56	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	57	1.92	1.92	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	58	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	59	0.78	0.78	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	60	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	61	4.68	4.68	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	62	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	63	CS$13.5	cs$13.5	$
work_4jheoe6s5jbc5lxgowinku6jgi	12	64	90	90	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	65	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	66	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	67	84	84	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	68	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	69	95	95	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	70	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	71	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	72	94±14	94±14	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	73	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	74	84±11	84±11	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	75	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	76	CS<13.5	cs<13.5	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	77	69	69	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	78	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	79	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	80	61	61	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	81	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	82	78	78	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	83	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	84	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	85	68±12	68±12	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	86	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	87	77±6	77±6	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	88	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	89	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	90	2.31	2.31	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	91	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	92	1.73	1.73	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	93	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	94	3.08	3.08	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	95	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	96	1.54	1.54	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	97	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	98	0.73	0.73	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	99	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	100	3.26	3.26	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	101	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	102	1.19	1.19	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	103	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	104	0.78	0.78	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	105	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	106	1.82	1.82	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	107	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	108	Graft	Graft	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	109	Failure	Failure	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	110	Probability	Probability	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	111	Duke	Duke	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	112	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	113	PDR	PDR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	114	SMF	SMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	115	PDR	PDR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	116	All	All	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	117	PCS$7.75	pcs$7.75	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	118	7	7	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	119	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	120	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	121	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	122	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	123	17	17	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	124	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	125	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	126	0±18	0±18	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	127	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	128	17±19	17±19	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	129	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	130	PCS$5.5	PCS$5.5	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	131	&	&	CC
work_4jheoe6s5jbc5lxgowinku6jgi	12	132	<	<	XX
work_4jheoe6s5jbc5lxgowinku6jgi	12	133	7.75	7.75	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	134	19	19	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	135	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	136	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	137	12	12	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	138	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	139	30	30	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	140	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	141	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	142	15±14	15±14	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	143	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	144	18±10	18±10	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	145	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	146	PCS$4.25	pcs$4.25	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	147	&	&	CC
work_4jheoe6s5jbc5lxgowinku6jgi	12	148	<	<	XX
work_4jheoe6s5jbc5lxgowinku6jgi	12	149	5.5	5.5	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	150	26	26	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	151	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	152	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	153	16	16	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	154	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	155	39	39	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	156	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	157	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	158	6±13	6±13	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	159	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	160	14±9	14±9	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	161	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	162	PCS<4.25	pcs<4.25	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	163	32	32	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	164	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	165	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	166	22	22	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	167	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	12	168	45	45	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	169	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	170	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	171	38±12	38±12	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	172	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	173	29±5	29±5	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	174	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	175	50	50	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	176	IN	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	12	177	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	12	178	VIVO	vivo	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	179	EXPANSION	expansion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	180	OF	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	12	181	T	T	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	182	REGULATORY	REGULATORY	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	183	CELLS	CELLS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	184	BY	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	12	185	RAPAMYCIN	RAPAMYCIN	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	186	IN	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	12	187	A	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	12	188	CALCINEURIN	CALCINEURIN	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	189	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	12	190	INHIBITOR	inhibitor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	191	FREE	free	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	12	192	GVHD	GVHD	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	12	193	PROPHYLAXIS	prophylaxi	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	12	194	IN	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	12	195	UNMANIPU-	unmanipu-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	12	196	LATED	late	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	12	197	HAPLOIDENTICAL	haploidentical	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	198	STEM	stem	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	199	CELL	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	200	TRANSPLANTATION	transplantation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	201	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	202	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	203	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	12	204	Peccatori	Peccatori	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	205	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	206	J.1	J.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	207	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	208	Clerici	Clerici	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	209	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	210	D.1	D.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	211	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	212	Forcina	Forcina	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	213	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	214	A.1	A.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	215	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	216	Bondanza	Bondanza	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	217	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	218	A.2	A.2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	219	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	220	Messina	Messina	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	221	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	222	C.1	C.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	223	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	224	Giglio	Giglio	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	225	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	226	F.1	F.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	227	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	228	Mastaglio	Mastaglio	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	229	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	230	S.1	S.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	231	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	232	Crotta	Crotta	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	233	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	234	A.1	A.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	235	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	236	Lupo	Lupo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	237	Stanghellini	Stanghellini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	238	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	239	M.T.1	M.T.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	240	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	241	Marcatti	Marcatti	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	242	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	243	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	244	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	245	Crocchiolo	Crocchiolo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	246	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	247	R.1	R.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	248	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	249	Assanelli	Assanelli	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	250	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	251	A.1	A.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	252	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	253	Bernardi	Bernardi	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	254	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	255	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	256	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	257	Corti	Corti	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	258	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	259	C.1	C.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	260	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	261	Noviello	Noviello	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	262	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	263	M.2	M.2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	264	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	265	Olek	Olek	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	266	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	267	S.3	S.3	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	268	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	269	Ferraro	Ferraro	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	270	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	271	A.4	A.4	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	272	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	273	Battagglia	Battagglia	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	274	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	275	M.4	M.4	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	276	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	277	Roncarolo	Roncarolo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	278	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	279	M.G.5	M.G.5	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	280	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	281	Locatelli	Locatelli	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	282	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	283	F.6	F.6	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	284	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	285	Bonini	Bonini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	286	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	287	C.2	C.2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	288	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	289	Ciceri	Ciceri	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	290	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	291	F.1	F.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	292	1San	1san	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	293	Raffaele	Raffaele	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	294	Scientific	Scientific	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	295	Institute	Institute	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	296	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	297	Mi-	Mi-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	298	lan	lan	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	299	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	300	Italy	Italy	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	301	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	12	302	2San	2san	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	303	Raffaele	Raffaele	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	304	Scientific	Scientific	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	305	Institute	Institute	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	306	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	307	Milan	Milan	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	308	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	309	Italy	Italy	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	310	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	12	311	3Epiontis	3Epiontis	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	312	Gmb	Gmb	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	313	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	314	Berlin	Berlin	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	315	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	316	Germany	Germany	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	317	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	12	318	4San	4san	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	319	Raffaele	Raffaele	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	320	Scientific	Scientific	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	321	Institute	Institute	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	322	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	323	Milan	Milan	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	324	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	325	Italy	Italy	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	326	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	12	327	5San	5san	CD
work_4jheoe6s5jbc5lxgowinku6jgi	12	328	Raf-	Raf-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	329	faele	faele	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	330	Scientific	Scientific	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	331	Institute	Institute	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	332	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	333	Milan	Milan	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	334	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	335	Italy	Italy	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	336	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	12	337	6IRCCS	6IRCCS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	338	Ospedale	Ospedale	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	339	Pediatrico	Pediatrico	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	340	Bambino	Bambino	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	341	Ges	Ges	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	342	�	�	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	343	u	u	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	344	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	345	Roma	Roma	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	346	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	12	347	Italy	Italy	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	348	Background	Background	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	349	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	12	350	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	12	351	are	be	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	12	352	attractive	attractive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	12	353	candidates	candidate	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	12	354	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	12	355	clinical	clinical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	12	356	modulation	modulation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	12	357	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	12	358	excessive	excessive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	12	359	immune	immune	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	12	360	responses	response	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	12	361	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	13	1	In	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	13	2	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	13	3	mouse	mouse	NN
work_4jheoe6s5jbc5lxgowinku6jgi	13	4	models	model	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	13	5	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	13	6	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	13	7	adoptive	adoptive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	13	8	transfer	transfer	NN
work_4jheoe6s5jbc5lxgowinku6jgi	13	9	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	13	10	purified	purify	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	13	11	natural	natural	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	13	12	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	13	13	has	have	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	13	14	been	be	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	13	15	shown	show	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	13	16	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	13	17	prevent	prevent	VB
work_4jheoe6s5jbc5lxgowinku6jgi	13	18	GvHD	GvHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	13	19	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	13	20	while	while	IN
work_4jheoe6s5jbc5lxgowinku6jgi	13	21	sparing	spare	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	13	22	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	13	23	significant	significant	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	13	24	GvL	gvl	NN
work_4jheoe6s5jbc5lxgowinku6jgi	13	25	effect	effect	NN
work_4jheoe6s5jbc5lxgowinku6jgi	13	26	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	14	1	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	14	2	’	’	POS
work_4jheoe6s5jbc5lxgowinku6jgi	14	3	suppressor	suppressor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	14	4	function	function	NN
work_4jheoe6s5jbc5lxgowinku6jgi	14	5	has	have	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	14	6	been	be	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	14	7	demonstrated	demonstrate	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	14	8	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	14	9	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	14	10	critically	critically	RB
work_4jheoe6s5jbc5lxgowinku6jgi	14	11	dependent	dependent	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	14	12	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	14	13	IL-2	IL-2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	14	14	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	14	15	therefore	therefore	RB
work_4jheoe6s5jbc5lxgowinku6jgi	14	16	cyA	cyA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	14	17	significantly	significantly	RB
work_4jheoe6s5jbc5lxgowinku6jgi	14	18	reduces	reduce	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	14	19	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	14	20	function	function	NN
work_4jheoe6s5jbc5lxgowinku6jgi	14	21	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	14	22	allostimulated	allostimulate	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	14	23	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	14	24	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	15	1	Aim	aim	VB
work_4jheoe6s5jbc5lxgowinku6jgi	15	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	15	3	To	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	15	4	address	address	VB
work_4jheoe6s5jbc5lxgowinku6jgi	15	5	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	15	6	role	role	NN
work_4jheoe6s5jbc5lxgowinku6jgi	15	7	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	15	8	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	15	9	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	15	10	human	human	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	15	11	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	15	12	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	15	13	we	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	15	14	focused	focus	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	15	15	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	15	16	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	15	17	calcineurin	calcineurin	NN
work_4jheoe6s5jbc5lxgowinku6jgi	15	18	inhibitor	inhibitor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	15	19	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	15	20	free	free	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	15	21	GvHD	GvHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	15	22	prophylaxis	prophylaxis	NN
work_4jheoe6s5jbc5lxgowinku6jgi	15	23	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	16	1	We	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	16	2	tested	test	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	16	3	this	this	DT
work_4jheoe6s5jbc5lxgowinku6jgi	16	4	hy-	hy-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	16	5	pothesis	pothesis	NN
work_4jheoe6s5jbc5lxgowinku6jgi	16	6	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	16	7	haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	16	8	peripheral	peripheral	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	16	9	blood	blood	NN
work_4jheoe6s5jbc5lxgowinku6jgi	16	10	stem	stem	NN
work_4jheoe6s5jbc5lxgowinku6jgi	16	11	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	16	12	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	16	13	without	without	IN
work_4jheoe6s5jbc5lxgowinku6jgi	16	14	any	any	DT
work_4jheoe6s5jbc5lxgowinku6jgi	16	15	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	16	16	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	16	17	vitro	vitro	FW
work_4jheoe6s5jbc5lxgowinku6jgi	16	18	manipulation	manipulation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	16	19	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	17	1	Patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	17	2	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	17	3	Methods	Methods	NNPS
work_4jheoe6s5jbc5lxgowinku6jgi	17	4	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	17	5	Since	since	IN
work_4jheoe6s5jbc5lxgowinku6jgi	17	6	2007	2007	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	7	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	17	8	68	68	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	9	pts	pt	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	17	10	underwent	undergo	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	17	11	allo	allo	NN
work_4jheoe6s5jbc5lxgowinku6jgi	17	12	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	17	13	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	17	14	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	17	15	AML	AML	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	17	16	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	17	43	43	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	18	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	19	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	17	20	ALL	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	17	21	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	22	9	9	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	23	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	24	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	17	25	MDS	MDS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	17	26	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	27	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	28	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	29	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	17	30	MPD	MPD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	17	31	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	32	4	4	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	33	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	34	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	17	35	NHL	NHL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	17	36	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	37	4	4	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	38	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	39	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	17	40	HD	HD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	17	41	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	42	5	5	CD
work_4jheoe6s5jbc5lxgowinku6jgi	17	43	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	17	44	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	18	1	Median	median	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	18	2	age	age	NN
work_4jheoe6s5jbc5lxgowinku6jgi	18	3	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	18	4	48	48	CD
work_4jheoe6s5jbc5lxgowinku6jgi	18	5	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	18	6	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	18	7	range	range	VB
work_4jheoe6s5jbc5lxgowinku6jgi	18	8	14	14	CD
work_4jheoe6s5jbc5lxgowinku6jgi	18	9	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	18	10	69	69	CD
work_4jheoe6s5jbc5lxgowinku6jgi	18	11	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	18	12	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	19	1	At	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	19	2	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	19	3	all	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	19	4	but	but	IN
work_4jheoe6s5jbc5lxgowinku6jgi	19	5	8	8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	19	6	pts	pt	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	19	7	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	19	8	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	19	9	advanced	advanced	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	19	10	phase	phase	NN
work_4jheoe6s5jbc5lxgowinku6jgi	19	11	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	20	1	Conditioning	Conditioning	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	2	included	include	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	20	3	Treosulfan	Treosulfan	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	4	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	5	14	14	CD
work_4jheoe6s5jbc5lxgowinku6jgi	20	6	g	g	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	7	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	20	8	m2	m2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	9	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	20	10	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	20	11	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	12	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	20	13	Fludara	Fludara	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	14	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	15	30	30	CD
work_4jheoe6s5jbc5lxgowinku6jgi	20	16	mg	mg	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	17	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	20	18	m2	m2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	19	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	20	20	5	5	CD
work_4jheoe6s5jbc5lxgowinku6jgi	20	21	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	22	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	20	23	an	an	DT
work_4jheoe6s5jbc5lxgowinku6jgi	20	24	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	20	25	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	20	26	vivo	vivo	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	27	T	t	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	28	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	20	29	B	b	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	30	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	20	31	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	32	depletion	depletion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	33	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	20	34	by	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	20	35	ATG-	ATG-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	36	Fresenius	Fresenius	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	37	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	38	10	10	CD
work_4jheoe6s5jbc5lxgowinku6jgi	20	39	mg	mg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	40	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	20	41	kg	kg	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	20	42	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	20	43	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	20	44	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	45	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	20	46	Mabthera	Mabthera	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	47	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	48	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	20	49	single	single	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	20	50	500	500	CD
work_4jheoe6s5jbc5lxgowinku6jgi	20	51	mg	mg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	20	52	dose	dose	NN
work_4jheoe6s5jbc5lxgowinku6jgi	20	53	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	20	54	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	21	1	All	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	21	2	pts	pt	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	21	3	received	receive	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	21	4	allogeneic	allogeneic	IN
work_4jheoe6s5jbc5lxgowinku6jgi	21	5	PBSC	pbsc	NN
work_4jheoe6s5jbc5lxgowinku6jgi	21	6	from	from	IN
work_4jheoe6s5jbc5lxgowinku6jgi	21	7	an	an	DT
work_4jheoe6s5jbc5lxgowinku6jgi	21	8	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	21	9	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	21	10	haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	21	11	related	relate	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	21	12	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	21	13	without	without	IN
work_4jheoe6s5jbc5lxgowinku6jgi	21	14	any	any	DT
work_4jheoe6s5jbc5lxgowinku6jgi	21	15	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	21	16	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	21	17	vitro	vitro	FW
work_4jheoe6s5jbc5lxgowinku6jgi	21	18	positive	positive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	21	19	selection	selection	NN
work_4jheoe6s5jbc5lxgowinku6jgi	21	20	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	22	1	GvHD	GvHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	2	prophy-	prophy-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	3	laxis	laxis	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	4	consisted	consist	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	22	5	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	22	6	Rapamycin	Rapamycin	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	7	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	22	8	target	target	VB
work_4jheoe6s5jbc5lxgowinku6jgi	22	9	level	level	NN
work_4jheoe6s5jbc5lxgowinku6jgi	22	10	8	8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	22	11	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	22	12	15	15	CD
work_4jheoe6s5jbc5lxgowinku6jgi	22	13	ng	ng	NN
work_4jheoe6s5jbc5lxgowinku6jgi	22	14	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	22	15	ml	ml	NN
work_4jheoe6s5jbc5lxgowinku6jgi	22	16	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	22	17	till	till	IN
work_4jheoe6s5jbc5lxgowinku6jgi	22	18	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	22	19	160	160	CD
work_4jheoe6s5jbc5lxgowinku6jgi	22	20	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	22	21	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	22	22	MMF	MMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	23	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	22	24	15	15	CD
work_4jheoe6s5jbc5lxgowinku6jgi	22	25	mg	mg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	26	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	22	27	kg	kg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	28	tid	tid	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	22	29	till	till	IN
work_4jheoe6s5jbc5lxgowinku6jgi	22	30	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	22	31	130	130	CD
work_4jheoe6s5jbc5lxgowinku6jgi	22	32	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	22	33	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	23	1	Results	result	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	23	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	23	3	All	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	23	4	pts	pt	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	23	5	but	but	CC
work_4jheoe6s5jbc5lxgowinku6jgi	23	6	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	23	7	had	have	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	23	8	neutrophil	neutrophil	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	23	9	engraftment	engraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	23	10	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	24	1	CI	CI	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	24	2	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	24	3	grade	grade	NN
work_4jheoe6s5jbc5lxgowinku6jgi	24	4	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	24	5	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	24	6	4	4	CD
work_4jheoe6s5jbc5lxgowinku6jgi	24	7	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	24	8	grade	grade	NN
work_4jheoe6s5jbc5lxgowinku6jgi	24	9	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	24	10	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	24	11	4	4	CD
work_4jheoe6s5jbc5lxgowinku6jgi	24	12	aGvHD	aGvHD	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	24	13	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	24	14	cGvHD	cGvHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	24	15	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	24	16	22	22	CD
work_4jheoe6s5jbc5lxgowinku6jgi	24	17	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	24	18	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	24	19	11	11	CD
work_4jheoe6s5jbc5lxgowinku6jgi	24	20	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	24	21	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	24	22	26	26	CD
work_4jheoe6s5jbc5lxgowinku6jgi	24	23	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	24	24	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	25	1	100	100	CD
work_4jheoe6s5jbc5lxgowinku6jgi	25	2	days	day	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	25	3	TRM	TRM	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	25	4	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	25	5	relapse	relapse	VB
work_4jheoe6s5jbc5lxgowinku6jgi	25	6	incidence	incidence	NN
work_4jheoe6s5jbc5lxgowinku6jgi	25	7	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	25	8	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	25	9	year	year	NN
work_4jheoe6s5jbc5lxgowinku6jgi	25	10	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	25	11	17	17	CD
work_4jheoe6s5jbc5lxgowinku6jgi	25	12	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	25	13	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	25	14	44	44	CD
work_4jheoe6s5jbc5lxgowinku6jgi	25	15	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	25	16	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	26	1	Projected	project	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	26	2	OS	OS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	26	3	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	26	4	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	26	5	year	year	NN
work_4jheoe6s5jbc5lxgowinku6jgi	26	6	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	26	7	39	39	CD
work_4jheoe6s5jbc5lxgowinku6jgi	26	8	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	26	9	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	27	1	Immunoreconstitution	immunoreconstitution	NN
work_4jheoe6s5jbc5lxgowinku6jgi	27	2	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	27	3	fast	fast	RB
work_4jheoe6s5jbc5lxgowinku6jgi	27	4	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	27	5	sustained	sustained	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	27	6	witha	witha	NN
work_4jheoe6s5jbc5lxgowinku6jgi	27	7	median	median	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	27	8	220	220	CD
work_4jheoe6s5jbc5lxgowinku6jgi	27	9	circulating	circulate	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	27	10	CD31cells	CD31cells	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	27	11	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	27	12	mL	mL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	27	13	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	27	14	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	27	15	130	130	CD
work_4jheoe6s5jbc5lxgowinku6jgi	27	16	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	28	1	We	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	28	2	detected	detect	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	28	3	high	high	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	28	4	levels	level	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	28	5	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	28	6	CD41CD251CD127-	CD41CD251CD127-	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	28	7	FOXP31	foxp31	NN
work_4jheoe6s5jbc5lxgowinku6jgi	28	8	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	28	9	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	28	10	up	up	IN
work_4jheoe6s5jbc5lxgowinku6jgi	28	11	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	28	12	30	30	CD
work_4jheoe6s5jbc5lxgowinku6jgi	28	13	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	28	14	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	28	15	circulating	circulate	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	28	16	CD41	CD41	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	28	17	T	T	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	28	18	lymphocytes	lymphocyte	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	28	19	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	28	20	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	28	21	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	28	22	130	130	CD
work_4jheoe6s5jbc5lxgowinku6jgi	28	23	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	29	1	These	these	DT
work_4jheoe6s5jbc5lxgowinku6jgi	29	2	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	29	3	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	29	4	able	able	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	29	5	tosuppressinvitroproliferationofautologouseffectorcells	tosuppressinvitroproliferationofautologouseffectorcell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	29	6	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	29	7	Thisobser-	Thisobser-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	29	8	vation	vation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	29	9	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	29	10	further	further	RB
work_4jheoe6s5jbc5lxgowinku6jgi	29	11	reinforced	reinforce	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	29	12	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	29	13	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	29	14	molecular	molecular	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	29	15	level	level	NN
work_4jheoe6s5jbc5lxgowinku6jgi	29	16	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	30	1	We	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	30	2	applied	apply	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	30	3	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	30	4	quanti-	quanti-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	5	tative	tative	CD
work_4jheoe6s5jbc5lxgowinku6jgi	30	6	RT	RT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	30	7	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	30	8	PCR	PCR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	30	9	based	base	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	30	10	methylation	methylation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	11	assay	assay	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	12	that	that	WDT
work_4jheoe6s5jbc5lxgowinku6jgi	30	13	enables	enable	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	30	14	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	30	15	specific	specific	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	30	16	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	30	17	sensitive	sensitive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	30	18	determination	determination	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	19	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	30	20	T	t	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	21	regs	reg	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	30	22	numbers	number	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	30	23	by	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	30	24	measuring	measure	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	30	25	demethylated	demethylate	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	30	26	FOXP3atT	FOXP3atT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	30	27	regspecific	regspecific	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	30	28	demethyletedregion	demethyletedregion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	29	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	30	30	TSDR).Anexpansion	tsdr).anexpansion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	31	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	30	32	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	30	33	carrying	carry	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	30	34	FOXP3	FOXP3	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	30	35	demethylation	demethylation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	36	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	30	37	evident	evident	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	30	38	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	30	39	our	-PRON-	PRP$
work_4jheoe6s5jbc5lxgowinku6jgi	30	40	pts	pts	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	41	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	30	42	but	but	CC
work_4jheoe6s5jbc5lxgowinku6jgi	30	43	not	not	RB
work_4jheoe6s5jbc5lxgowinku6jgi	30	44	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	30	45	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	30	46	control	control	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	47	group	group	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	48	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	30	49	pts	pts	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	30	50	receiving	receiving	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	51	mismatched	mismatch	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	30	52	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	30	53	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	30	54	cyclosporine	cyclosporine	NN
work_4jheoe6s5jbc5lxgowinku6jgi	30	55	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	31	1	Conclusions	conclusion	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	31	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	31	3	Rapamycin	Rapamycin	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	31	4	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	31	5	Mycophenolate	Mycophenolate	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	31	6	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	31	7	ATG	ATG	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	31	8	are	be	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	31	9	effective	effective	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	31	10	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	31	11	GvHD	GvHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	31	12	prophylaxis	prophylaxis	NN
work_4jheoe6s5jbc5lxgowinku6jgi	31	13	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	31	14	unmanipulated	unmanipulated	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	31	15	haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	31	16	peripheral	peripheral	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	31	17	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	31	18	andareassociatedwith	andareassociatedwith	NN
work_4jheoe6s5jbc5lxgowinku6jgi	31	19	anearlyT	anearlyT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	31	20	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	31	21	cellimmunoreconstitutioncharacter-	cellimmunoreconstitutioncharacter-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	31	22	ized	ize	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	31	23	by	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	31	24	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	31	25	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	31	26	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	31	27	vivo	vivo	NN
work_4jheoe6s5jbc5lxgowinku6jgi	31	28	expansion	expansion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	31	29	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	31	30	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	31	31	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	32	1	Further	further	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	32	2	studies	study	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	32	3	are	be	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	32	4	warranted	warrant	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	32	5	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	32	6	gain	gain	VB
work_4jheoe6s5jbc5lxgowinku6jgi	32	7	insight	insight	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	32	8	correlations	correlation	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	32	9	between	between	IN
work_4jheoe6s5jbc5lxgowinku6jgi	32	10	Tregs	Tregs	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	32	11	expansion	expansion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	32	12	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	32	13	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	32	14	outcome	outcome	NN
work_4jheoe6s5jbc5lxgowinku6jgi	32	15	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	33	1	51	51	CD
work_4jheoe6s5jbc5lxgowinku6jgi	33	2	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	33	3	HIGH	HIGH	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	4	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	33	5	RESOLUTION	resolution	NN
work_4jheoe6s5jbc5lxgowinku6jgi	33	6	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	7	MATCH	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	33	8	RATE	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	33	9	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	33	10	THE	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	33	11	IMPACT	IMPACT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	12	OF	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	33	13	RACE	RACE	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	14	Dehn	Dehn	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	15	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	16	J.1	J.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	17	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	18	Buck	Buck	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	19	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	20	K.1	K.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	21	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	22	Yang	Yang	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	23	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	24	S.Y.2	S.Y.2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	25	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	26	Schmidt	Schmidt	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	27	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	28	A.3	A.3	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	29	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	30	Hartzman	Hartzman	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	31	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	32	R.4	R.4	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	33	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	34	Maiers	Maiers	NNPS
work_4jheoe6s5jbc5lxgowinku6jgi	33	35	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	36	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	37	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	38	Setterholm	Setterholm	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	39	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	40	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	41	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	42	Confer	Confer	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	43	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	44	D.1	D.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	45	1National	1National	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	46	Marrow	Marrow	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	47	Donor	Donor	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	48	Program	Program	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	49	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	50	Minneapolis	Minneapolis	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	51	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	52	MN	MN	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	53	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	33	54	2Histogenetics	2Histogenetics	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	55	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	56	Inc.	Inc.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	57	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	58	Ossining	Ossining	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	59	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	60	NY	NY	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	61	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	33	62	3DKMS	3dkms	CD
work_4jheoe6s5jbc5lxgowinku6jgi	33	63	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	64	Tuebingen	Tuebingen	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	65	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	33	66	Germany	Germany	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	33	67	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	33	68	4C.W.	4c.w.	ADD
work_4jheoe6s5jbc5lxgowinku6jgi	34	1	Bill	Bill	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	2	Young	Young	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	3	Marrow	Marrow	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	4	Donor	Donor	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	5	Re-	Re-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	6	cruitment	cruitment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	7	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	34	8	Research	Research	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	9	Program	Program	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	10	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	34	11	Rockville	Rockville	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	12	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	34	13	MD	MD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	14	Aim	Aim	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	15	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	34	16	Calculation	Calculation	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	17	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	34	18	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	34	19	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	34	20	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	34	21	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	22	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	34	23	A	A	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	24	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	34	25	B	b	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	26	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	34	27	C	C	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	28	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	34	29	DRB1	DRB1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	30	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	34	31	high	high	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	34	32	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	34	33	resolution	resolution	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	34	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	34	35	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	36	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	34	37	match	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	38	rate	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	39	using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	34	40	real	real	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	34	41	patient	patient	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	42	unrelated	unrelated	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	34	43	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	44	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	34	45	URD	URD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	34	46	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	34	47	searches	search	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	34	48	presents	present	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	34	49	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	34	50	biased	biased	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	34	51	sample	sample	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	52	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	34	53	reasons	reason	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	34	54	including	include	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	34	55	access	access	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	56	to	to	IN
work_4jheoe6s5jbc5lxgowinku6jgi	34	57	treatment	treatment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	58	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	34	59	fi-	fi-	XX
work_4jheoe6s5jbc5lxgowinku6jgi	34	60	nancial	nancial	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	34	61	barriers	barrier	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	34	62	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	34	63	incomplete	incomplete	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	34	64	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	65	testing	testing	NN
work_4jheoe6s5jbc5lxgowinku6jgi	34	66	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	35	1	A	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	35	2	study	study	NN
work_4jheoe6s5jbc5lxgowinku6jgi	35	3	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	35	4	designed	design	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	35	5	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	35	6	estimate	estimate	VB
work_4jheoe6s5jbc5lxgowinku6jgi	35	7	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	35	8	true	true	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	35	9	match	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	35	10	rate	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	35	11	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	35	12	Caucasian	Caucasian	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	13	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	14	CAU	CAU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	15	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	16	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	35	17	Hispanic	Hispanic	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	18	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	19	HIS	his	PRP$
work_4jheoe6s5jbc5lxgowinku6jgi	35	20	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	21	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	35	22	Asian	Asian	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	23	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	35	24	Pacific	Pacific	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	25	Islander	Islander	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	26	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	27	API	API	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	28	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	29	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	35	30	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	35	31	African	african	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	35	32	American	American	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	33	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	34	AFA	AFA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	35	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	35	36	groups	group	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	35	37	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	35	38	representing	represent	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	35	39	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	35	40	four	four	CD
work_4jheoe6s5jbc5lxgowinku6jgi	35	41	largest	large	JJS
work_4jheoe6s5jbc5lxgowinku6jgi	35	42	race	race	NN
work_4jheoe6s5jbc5lxgowinku6jgi	35	43	groups	group	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	35	44	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	35	45	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	35	46	US	US	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	35	47	population	population	NN
work_4jheoe6s5jbc5lxgowinku6jgi	35	48	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	36	1	Methods	method	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	36	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	36	3	1344	1344	CD
work_4jheoe6s5jbc5lxgowinku6jgi	36	4	URD	URD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	36	5	searches	search	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	36	6	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	36	7	performed	perform	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	36	8	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	36	9	pseudopatients	pseudopatient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	36	10	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	36	11	PP	PP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	36	12	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	36	13	who	who	WP
work_4jheoe6s5jbc5lxgowinku6jgi	36	14	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	36	15	randomly	randomly	RB
work_4jheoe6s5jbc5lxgowinku6jgi	36	16	selected	select	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	36	17	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	36	18	previously	previously	RB
work_4jheoe6s5jbc5lxgowinku6jgi	36	19	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	36	20	tested	test	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	36	21	donors	donor	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	36	22	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	36	23	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	36	24	NMDP	NMDP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	36	25	’s	’s	,
work_4jheoe6s5jbc5lxgowinku6jgi	36	26	Be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	36	27	The	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	36	28	Match	Match	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	36	29	Registry	Registry	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	36	30	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	36	31	BTMR	BTMR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	36	32	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	36	33	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	37	1	Searches	search	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	37	2	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	37	3	based	base	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	37	4	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	37	5	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	37	6	fixed	fix	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	37	7	BTMR	BTMR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	37	8	file	file	NN
work_4jheoe6s5jbc5lxgowinku6jgi	37	9	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	37	10	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	37	11	January	January	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	37	12	2009	2009	CD
work_4jheoe6s5jbc5lxgowinku6jgi	37	13	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	38	1	Search	search	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	2	results	result	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	38	3	from	from	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	4	CAU	CAU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	5	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	38	6	HIS	HIS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	7	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	38	8	API	API	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	9	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	38	10	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	38	11	AFA	AFA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	12	PP	PP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	13	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	38	14	classified	classify	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	38	15	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	16	follows	follow	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	38	17	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	38	18	Oral	Oral	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	19	Presentations	Presentations	NNPS
work_4jheoe6s5jbc5lxgowinku6jgi	38	20	S171	S171	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	21	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	22	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	38	23	At	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	24	least	least	RBS
work_4jheoe6s5jbc5lxgowinku6jgi	38	25	one	one	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	26	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	27	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	28	matched	match	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	38	29	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	30	exists	exist	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	38	31	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	32	BTMR	BTMR	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	38	33	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	34	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	38	35	No	no	DT
work_4jheoe6s5jbc5lxgowinku6jgi	38	36	potential	potential	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	38	37	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	38	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	39	donors	donor	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	38	40	exist	exist	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	38	41	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	42	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	38	43	Potential	potential	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	38	44	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	45	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	46	donors	donor	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	38	47	exist	exist	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	38	48	PP	PP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	49	searches	search	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	38	50	falling	fall	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	38	51	into	into	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	52	category	category	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	53	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	54	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	38	55	accrued	accrue	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	38	56	until	until	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	57	N	N	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	58	5	5	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	59	200	200	CD
work_4jheoe6s5jbc5lxgowinku6jgi	38	60	per	per	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	61	race	race	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	62	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	38	63	then	then	RB
work_4jheoe6s5jbc5lxgowinku6jgi	38	64	had	have	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	38	65	an	an	DT
work_4jheoe6s5jbc5lxgowinku6jgi	38	66	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	67	search	search	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	68	strategy	strategy	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	69	expert	expert	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	70	rank	rank	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	38	71	potential	potential	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	38	72	donors	donor	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	38	73	within	within	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	74	BTMRinorder	btmrinorder	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	75	oftheirmatchinglikelihood	oftheirmatchinglikelihood	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	76	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	38	77	Previouslystoreddonor	previouslystoreddonor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	78	samples	sample	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	38	79	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	38	80	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	81	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	38	82	tested	test	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	38	83	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	84	order	order	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	85	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	38	86	ranking	rank	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	38	87	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	38	88	evaluated	evaluate	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	38	89	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	38	90	de-	de-	RB
work_4jheoe6s5jbc5lxgowinku6jgi	38	91	termine	termine	VB
work_4jheoe6s5jbc5lxgowinku6jgi	38	92	match	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	93	status	status	NN
work_4jheoe6s5jbc5lxgowinku6jgi	38	94	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	39	1	Consecutive	consecutive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	39	2	rounds	round	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	39	3	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	39	4	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	39	5	sample	sample	NN
work_4jheoe6s5jbc5lxgowinku6jgi	39	6	testing	testing	NN
work_4jheoe6s5jbc5lxgowinku6jgi	39	7	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	39	8	performed	perform	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	39	9	until	until	IN
work_4jheoe6s5jbc5lxgowinku6jgi	39	10	either	either	CC
work_4jheoe6s5jbc5lxgowinku6jgi	39	11	an	an	DT
work_4jheoe6s5jbc5lxgowinku6jgi	39	12	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	39	13	matched	match	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	39	14	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	39	15	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	39	16	identified	identify	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	39	17	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	39	18	no	no	DT
work_4jheoe6s5jbc5lxgowinku6jgi	39	19	potential	potential	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	39	20	donors	donor	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	39	21	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	39	22	stored	store	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	39	23	samples	sample	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	39	24	remained	remain	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	39	25	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	40	1	Results	result	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	40	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	40	3	The	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	40	4	table	table	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	5	below	below	RB
work_4jheoe6s5jbc5lxgowinku6jgi	40	6	shows	show	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	40	7	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	40	8	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	40	9	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	10	match	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	11	rate	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	12	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	40	13	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	40	14	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	40	15	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	40	16	68	68	CD
work_4jheoe6s5jbc5lxgowinku6jgi	40	17	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	18	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	40	19	CAU	CAU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	40	20	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	40	21	42	42	CD
work_4jheoe6s5jbc5lxgowinku6jgi	40	22	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	23	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	40	24	HIS	his	PRP$
work_4jheoe6s5jbc5lxgowinku6jgi	40	25	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	40	26	45	45	CD
work_4jheoe6s5jbc5lxgowinku6jgi	40	27	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	28	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	40	29	API	API	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	40	30	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	40	31	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	40	32	27	27	CD
work_4jheoe6s5jbc5lxgowinku6jgi	40	33	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	40	34	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	40	35	AFA	AFA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	40	36	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	41	1	Careful	careful	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	41	2	review	review	NN
work_4jheoe6s5jbc5lxgowinku6jgi	41	3	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	41	4	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	41	5	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	41	6	‘	'	``
work_4jheoe6s5jbc5lxgowinku6jgi	41	7	‘	'	``
work_4jheoe6s5jbc5lxgowinku6jgi	41	8	Pending	pende	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	41	9	further	further	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	41	10	testing	testing	NN
work_4jheoe6s5jbc5lxgowinku6jgi	41	11	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	41	12	no	no	DT
work_4jheoe6s5jbc5lxgowinku6jgi	41	13	stored	stored	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	41	14	sample	sample	NN
work_4jheoe6s5jbc5lxgowinku6jgi	41	15	’	'	''
work_4jheoe6s5jbc5lxgowinku6jgi	41	16	’	'	''
work_4jheoe6s5jbc5lxgowinku6jgi	41	17	sug-	sug-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	41	18	gests	gest	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	41	19	that	that	IN
work_4jheoe6s5jbc5lxgowinku6jgi	41	20	few	few	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	41	21	additional	additional	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	41	22	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	41	23	would	would	MD
work_4jheoe6s5jbc5lxgowinku6jgi	41	24	yield	yield	VB
work_4jheoe6s5jbc5lxgowinku6jgi	41	25	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	41	26	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	41	27	matches	match	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	41	28	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	42	1	CAU	CAU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	2	PP	PP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	3	HIS	his	PRP$
work_4jheoe6s5jbc5lxgowinku6jgi	42	4	PP	PP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	5	API	API	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	6	PP	PP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	7	AFA	AFA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	8	PP	PP	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	9	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	10	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	11	Matched	match	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	42	12	258	258	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	13	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	14	68	68	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	15	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	16	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	17	128	128	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	18	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	19	42	42	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	20	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	21	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	22	122	122	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	23	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	24	45	45	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	25	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	26	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	27	105	105	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	28	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	29	27	27	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	30	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	31	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	32	Pending	pende	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	42	33	Further	further	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	42	34	Testing	testing	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	35	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	42	36	No	no	DT
work_4jheoe6s5jbc5lxgowinku6jgi	42	37	Stored	Stored	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	38	Sample	Sample	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	39	48	48	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	40	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	41	13	13	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	42	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	43	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	44	65	65	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	45	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	46	21	21	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	47	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	48	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	49	57	57	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	50	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	51	21	21	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	52	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	53	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	54	54	54	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	55	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	56	14	14	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	57	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	58	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	59	No	no	UH
work_4jheoe6s5jbc5lxgowinku6jgi	42	60	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	61	HR	hr	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	62	Match	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	63	71	71	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	64	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	65	19	19	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	66	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	67	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	68	114	114	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	69	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	70	37	37	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	71	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	72	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	73	91	91	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	74	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	75	34	34	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	76	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	77	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	78	231	231	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	79	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	80	59	59	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	81	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	42	82	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	42	83	TOTAL	TOTAL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	84	377	377	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	85	307	307	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	86	270	270	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	87	390	390	CD
work_4jheoe6s5jbc5lxgowinku6jgi	42	88	Conclusions	Conclusions	NNPS
work_4jheoe6s5jbc5lxgowinku6jgi	42	89	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	42	90	Thisstudyprovidesatrue8/8HRmatchrateestimatefor	Thisstudyprovidesatrue8/8HRmatchrateestimatefor	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	91	CAU	CAU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	92	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	42	93	HIS	HIS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	94	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	42	95	API	API	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	96	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	42	97	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	42	98	AFA	AFA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	99	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	42	100	through	through	IN
work_4jheoe6s5jbc5lxgowinku6jgi	42	101	BTMR	BTMR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	42	102	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	42	103	which	which	WDT
work_4jheoe6s5jbc5lxgowinku6jgi	42	104	has	have	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	42	105	not	not	RB
work_4jheoe6s5jbc5lxgowinku6jgi	42	106	been	be	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	42	107	accomplished	accomplish	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	42	108	previously	previously	RB
work_4jheoe6s5jbc5lxgowinku6jgi	42	109	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	43	1	These	these	DT
work_4jheoe6s5jbc5lxgowinku6jgi	43	2	results	result	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	43	3	demonstrate	demonstrate	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	43	4	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	43	5	racial	racial	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	43	6	disparity	disparity	NN
work_4jheoe6s5jbc5lxgowinku6jgi	43	7	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	43	8	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	43	9	match	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	43	10	rates	rate	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	43	11	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	43	12	can	can	MD
work_4jheoe6s5jbc5lxgowinku6jgi	43	13	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	43	14	used	use	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	43	15	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	43	16	inform	inform	VB
work_4jheoe6s5jbc5lxgowinku6jgi	43	17	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	43	18	searching	search	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	43	19	BTMR.Thisstudyalsoprovidesvitalinformationfordonorrecruitment	btmr.thisstudyalsoprovidesvitalinformationfordonorrecruitment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	43	20	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	43	21	availability	availability	NN
work_4jheoe6s5jbc5lxgowinku6jgi	43	22	efforts	effort	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	43	23	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	44	1	Results	result	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	44	2	provide	provide	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	44	3	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	44	4	baseline	baseline	NN
work_4jheoe6s5jbc5lxgowinku6jgi	44	5	match	match	NN
work_4jheoe6s5jbc5lxgowinku6jgi	44	6	rate	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	44	7	that	that	WDT
work_4jheoe6s5jbc5lxgowinku6jgi	44	8	can	can	MD
work_4jheoe6s5jbc5lxgowinku6jgi	44	9	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	44	10	further	further	RB
work_4jheoe6s5jbc5lxgowinku6jgi	44	11	supplemented	supplement	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	44	12	using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	44	13	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	44	14	additional	additional	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	44	15	worldwide	worldwide	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	44	16	URD	URD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	44	17	inventory	inventory	NN
work_4jheoe6s5jbc5lxgowinku6jgi	44	18	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	45	1	52	52	CD
work_4jheoe6s5jbc5lxgowinku6jgi	45	2	A	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	45	3	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	45	4	STEP	step	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	5	APPROACH	APPROACH	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	45	6	TO	to	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	7	MYELOABLATIVE	myeloablative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	45	8	HAPLOIDENTICAL	HAPLOIDENTICAL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	9	HEMATO-	HEMATO-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	10	POIETIC	POIETIC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	11	STEM	STEM	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	12	CELL	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	13	TRANSPLANATION	transplanation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	14	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	45	15	HSCT	HSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	16	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	45	17	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	45	18	REPORT	report	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	19	OF	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	20	A	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	45	21	PHASE	phase	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	22	II	ii	CD
work_4jheoe6s5jbc5lxgowinku6jgi	45	23	TRIAL	trial	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	24	WITH	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	25	18	18	CD
work_4jheoe6s5jbc5lxgowinku6jgi	45	26	MONTHS	month	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	45	27	OF	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	28	FOLLOW	FOLLOW	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	29	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	45	30	UP	up	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	31	FOR	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	32	ALL	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	45	33	PATIENTS	PATIENTS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	34	Grosso	Grosso	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	35	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	36	D.1	D.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	37	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	38	Carabasi	Carabasi	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	39	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	40	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	41	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	42	Colombe	Colombe	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	43	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	44	B.2	B.2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	45	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	46	Cornett	Cornett	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	47	Farley	Farley	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	48	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	49	P.3	P.3	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	50	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	51	Flomenberg	Flomenberg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	52	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	53	P.4	P.4	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	54	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	55	Filicko	Filicko	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	56	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	45	57	O’Hara	O’Hara	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	58	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	59	J.1	J.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	60	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	61	Kasner	Kasner	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	62	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	63	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	64	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	65	O’Hara	O’Hara	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	66	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	67	W.5	W.5	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	68	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	69	Wagner	Wagner	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	70	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	71	J.L.1	J.L.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	72	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	73	Weiss	Weiss	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	74	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	75	M.1	M.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	76	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	77	Werner	Werner	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	78	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	45	79	Wasik	Wasik	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	80	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	81	M.6	M.6	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	82	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	83	Flomenberg	Flomenberg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	84	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	85	N.1	N.1	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	86	1Thomas	1Thomas	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	87	Jefferson	Jefferson	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	88	Kimmel	Kimmel	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	89	Cancer	Cancer	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	90	Center	Center	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	91	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	92	Philadelphia	Philadelphia	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	93	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	94	PA	pa	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	95	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	45	96	2Thomas	2Thomas	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	97	Jef-	Jef-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	98	ferson	ferson	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	99	University	University	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	100	Hospital	Hospital	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	101	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	102	Philadelphia	Philadelphia	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	103	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	104	PA	PA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	105	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	45	106	3Thomas	3Thomas	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	107	Jefferson	Jefferson	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	108	University	University	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	109	Hospital	Hospital	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	110	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	111	Philadelphia	Philadelphia	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	112	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	113	PA	pa	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	114	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	45	115	4Thomas	4Thomas	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	116	Jefferson	Jefferson	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	117	University	University	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	118	Hospital	Hospital	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	119	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	120	Phila-	Phila-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	121	delphia	delphia	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	122	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	123	PA	PA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	124	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	45	125	5Thomas	5Thomas	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	126	Jefferson	Jefferson	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	127	University	University	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	128	Hospital	Hospital	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	129	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	130	Philadelphia	Philadelphia	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	131	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	132	PA	PA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	133	;	;	:
work_4jheoe6s5jbc5lxgowinku6jgi	45	134	6Thomas	6Thomas	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	135	Jefferson	Jefferson	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	136	University	University	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	137	Hospital	Hospital	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	138	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	139	Philadelphia	Philadelphia	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	140	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	45	141	PA	PA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	142	Haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	45	143	HSCT	hsct	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	144	using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	45	145	post	post	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	146	transplant	transplant	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	147	cyclophosphamide	cyclophosphamide	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	148	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	45	149	CY	CY	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	150	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	45	151	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	152	elimination	elimination	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	153	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	154	alloreactive	alloreactive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	45	155	lymphocytes	lymphocyte	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	45	156	has	have	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	45	157	been	be	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	45	158	reported	report	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	45	159	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	160	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	45	161	safe	safe	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	45	162	option	option	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	163	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	45	164	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	45	165	lacking	lack	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	45	166	an	an	DT
work_4jheoe6s5jbc5lxgowinku6jgi	45	167	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	45	168	identical	identical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	45	169	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	45	170	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	46	1	We	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	46	2	re-	re-	RB
work_4jheoe6s5jbc5lxgowinku6jgi	46	3	port	port	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	46	4	an	an	DT
work_4jheoe6s5jbc5lxgowinku6jgi	46	5	alternate	alternate	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	46	6	approach	approach	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	7	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	8	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	46	9	following	follow	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	46	10	salient	salient	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	11	differences	difference	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	46	12	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	46	13	mye-	mye-	DT
work_4jheoe6s5jbc5lxgowinku6jgi	46	14	loablative	loablative	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	46	15	vs	vs	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	16	non	non	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	46	17	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	46	18	myeloablative	myeloablative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	46	19	conditioning	conditioning	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	20	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	46	21	peripheral	peripheral	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	46	22	blood	blood	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	23	rather	rather	RB
work_4jheoe6s5jbc5lxgowinku6jgi	46	24	than	than	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	25	marrow	marrow	VB
work_4jheoe6s5jbc5lxgowinku6jgi	46	26	stem	stem	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	27	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	28	source	source	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	29	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	46	30	no	no	DT
work_4jheoe6s5jbc5lxgowinku6jgi	46	31	exposure	exposure	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	32	vs	vs	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	33	exposure	exposure	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	34	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	35	HSC	HSC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	46	36	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	46	37	cy-	cy-	VB
work_4jheoe6s5jbc5lxgowinku6jgi	46	38	clophosphamide	clophosphamide	VB
work_4jheoe6s5jbc5lxgowinku6jgi	46	39	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	46	40	higher	high	JJR
work_4jheoe6s5jbc5lxgowinku6jgi	46	41	fixed	fix	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	46	42	number	number	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	43	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	44	CD3	cd3	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	45	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	46	46	versus	versus	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	47	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	46	48	lower	low	JJR
work_4jheoe6s5jbc5lxgowinku6jgi	46	49	var-	var-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	50	iable	iable	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	46	51	number	number	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	52	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	53	CD3	cd3	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	54	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	46	55	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	46	56	each	each	DT
work_4jheoe6s5jbc5lxgowinku6jgi	46	57	graft	graft	NN
work_4jheoe6s5jbc5lxgowinku6jgi	46	58	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	47	1	Results	result	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	47	2	are	be	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	47	3	reported	report	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	47	4	now	now	RB
work_4jheoe6s5jbc5lxgowinku6jgi	47	5	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	47	6	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	47	7	followed	follow	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	47	8	up	up	RP
work_4jheoe6s5jbc5lxgowinku6jgi	47	9	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	47	10	18	18	CD
work_4jheoe6s5jbc5lxgowinku6jgi	47	11	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	47	12	46	46	CD
work_4jheoe6s5jbc5lxgowinku6jgi	47	13	months	month	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	47	14	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	48	1	Table	table	NN
work_4jheoe6s5jbc5lxgowinku6jgi	48	2	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	48	3	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	49	1	Patient	Patient	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	2	Characteristics-2	Characteristics-2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	3	Step	Step	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	4	Approach	Approach	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	5	Age	Age	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	6	52	52	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	7	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	8	19	19	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	9	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	49	10	67	67	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	11	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	12	AML	AML	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	13	16	16	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	14	Remission	Remission	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	15	7	7	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	16	Resistant	Resistant	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	17	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	49	18	PIF	PIF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	19	9	9	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	20	Biphenotypic	Biphenotypic	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	21	Leukemia	Leukemia	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	22	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	23	Active	Active	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	24	Disease	Disease	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	25	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	26	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	27	ALL	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	49	28	4	4	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	29	CR2	CR2	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	30	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	31	ph-	ph-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	32	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	33	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	34	Persistent	Persistent	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	35	Disease	Disease	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	36	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	37	PH+	ph+	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	38	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	39	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	40	MDS	mds	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	41	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	42	NHL	NHL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	43	Resistant	Resistant	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	44	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	45	SAA	saa	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	46	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	47	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	48	MM	MM	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	49	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	50	GVH	GVH	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	51	Direction	Direction	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	52	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	53	4	4	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	54	13	13	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	55	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	56	11	11	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	57	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	58	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	59	0	0	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	60	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	61	Patients	Patients	NNPS
work_4jheoe6s5jbc5lxgowinku6jgi	49	62	received	receive	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	49	63	12	12	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	64	Gy	Gy	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	49	65	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	49	66	total	total	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	49	67	body	body	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	68	irradiation	irradiation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	69	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	70	TBI	TBI	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	71	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	72	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	49	73	followed	follow	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	49	74	by	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	49	75	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	49	76	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	77	lymphocyte	lymphocyte	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	78	product	product	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	79	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	80	DLI	DLI	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	81	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	82	containing	contain	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	49	83	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	84	�	�	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	85	10e8	10e8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	86	CD31	CD31	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	49	87	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	49	88	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	49	89	kg	kg	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	49	90	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	91	Step	step	NN
work_4jheoe6s5jbc5lxgowinku6jgi	49	92	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	49	93	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	49	94	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	50	1	This	this	DT
work_4jheoe6s5jbc5lxgowinku6jgi	50	2	large	large	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	50	3	dose	dose	NN
work_4jheoe6s5jbc5lxgowinku6jgi	50	4	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	50	5	haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	50	6	lymphocytes	lymphocyte	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	50	7	re-	re-	RB
work_4jheoe6s5jbc5lxgowinku6jgi	50	8	sulted	sulte	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	50	9	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	50	10	fever	fever	NN
work_4jheoe6s5jbc5lxgowinku6jgi	50	11	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	50	12	median	median	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	50	13	temperature	temperature	NN
work_4jheoe6s5jbc5lxgowinku6jgi	50	14	103.8	103.8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	50	15	�	�	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	50	16	f	f	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	50	17	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	50	18	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	50	19	diarrhea	diarrhea	NN
work_4jheoe6s5jbc5lxgowinku6jgi	50	20	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	50	21	rash	rash	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	50	22	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	51	1	CY	CY	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	51	2	60	60	CD
work_4jheoe6s5jbc5lxgowinku6jgi	51	3	mg	mg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	51	4	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	51	5	kg	kg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	51	6	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	51	7	given	give	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	51	8	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	51	9	days	day	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	51	10	-3	-3	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	51	11	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	51	12	-2	-2	,
work_4jheoe6s5jbc5lxgowinku6jgi	51	13	resulting	result	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	51	14	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	51	15	resolution	resolution	NN
work_4jheoe6s5jbc5lxgowinku6jgi	51	16	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	51	17	symp-	symp-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	51	18	toms	tom	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	51	19	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	52	1	Tacrolimus	Tacrolimus	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	52	2	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	52	3	MMF	MMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	52	4	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	52	5	begun	begin	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	52	6	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	52	7	day-1	day-1	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	52	8	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	53	1	A	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	53	2	CD	CD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	53	3	34	34	CD
work_4jheoe6s5jbc5lxgowinku6jgi	53	4	selected	select	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	53	5	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	53	6	product	product	NN
work_4jheoe6s5jbc5lxgowinku6jgi	53	7	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	53	8	infused	infuse	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	53	9	on	on	IN
work_4jheoe6s5jbc5lxgowinku6jgi	53	10	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	53	11	0	0	CD
work_4jheoe6s5jbc5lxgowinku6jgi	53	12	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	53	13	Step	step	NN
work_4jheoe6s5jbc5lxgowinku6jgi	53	14	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	53	15	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	53	16	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	54	1	Two	two	CD
work_4jheoe6s5jbc5lxgowinku6jgi	54	2	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	54	3	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	54	4	27	27	CD
work_4jheoe6s5jbc5lxgowinku6jgi	54	5	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	54	6	died	die	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	54	7	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	54	8	toxicity	toxicity	NN
work_4jheoe6s5jbc5lxgowinku6jgi	54	9	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	54	10	infection	infection	NN
work_4jheoe6s5jbc5lxgowinku6jgi	54	11	before	before	IN
work_4jheoe6s5jbc5lxgowinku6jgi	54	12	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	54	13	14	14	CD
work_4jheoe6s5jbc5lxgowinku6jgi	54	14	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	55	1	Of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	55	2	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	55	3	remaining	remain	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	55	4	25	25	CD
work_4jheoe6s5jbc5lxgowinku6jgi	55	5	pa-	pa-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	55	6	tients	tient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	55	7	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	55	8	23	23	CD
work_4jheoe6s5jbc5lxgowinku6jgi	55	9	had	have	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	55	10	complete	complete	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	55	11	engraftment	engraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	55	12	while	while	IN
work_4jheoe6s5jbc5lxgowinku6jgi	55	13	two	two	CD
work_4jheoe6s5jbc5lxgowinku6jgi	55	14	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	55	15	pre	pre	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	55	16	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	55	17	existing	existing	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	55	18	anti	anti	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	55	19	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	55	20	donor	donor	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	55	21	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	55	22	antibodies	antibody	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	55	23	failed	fail	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	55	24	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	55	25	engraft	engraft	VB
work_4jheoe6s5jbc5lxgowinku6jgi	55	26	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	56	1	Only	only	RB
work_4jheoe6s5jbc5lxgowinku6jgi	56	2	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	56	3	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	56	4	25	25	CD
work_4jheoe6s5jbc5lxgowinku6jgi	56	5	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	56	6	8	8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	56	7	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	56	8	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	56	9	pa-	pa-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	56	10	tients	tient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	56	11	developed	develop	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	56	12	severe	severe	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	56	13	acute	acute	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	56	14	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	56	15	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	56	16	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	56	17	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	56	18	25	25	CD
work_4jheoe6s5jbc5lxgowinku6jgi	56	19	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	56	20	12	12	CD
work_4jheoe6s5jbc5lxgowinku6jgi	56	21	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	56	22	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	56	23	developed	develop	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	56	24	limited	limited	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	56	25	chronic	chronic	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	56	26	GVHD	gvhd	NN
work_4jheoe6s5jbc5lxgowinku6jgi	56	27	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	56	28	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	56	29	no	no	DT
work_4jheoe6s5jbc5lxgowinku6jgi	56	30	patient	patient	NN
work_4jheoe6s5jbc5lxgowinku6jgi	56	31	died	die	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	56	32	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	56	33	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	56	34	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	57	1	Only	only	RB
work_4jheoe6s5jbc5lxgowinku6jgi	57	2	two	two	CD
work_4jheoe6s5jbc5lxgowinku6jgi	57	3	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	57	4	25	25	CD
work_4jheoe6s5jbc5lxgowinku6jgi	57	5	pa-	pa-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	57	6	tients	tient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	57	7	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	57	8	8	8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	57	9	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	57	10	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	57	11	died	die	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	57	12	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	57	13	infection	infection	NN
work_4jheoe6s5jbc5lxgowinku6jgi	57	14	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	58	1	Of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	58	2	16	16	CD
work_4jheoe6s5jbc5lxgowinku6jgi	58	3	disease	disease	NN
work_4jheoe6s5jbc5lxgowinku6jgi	58	4	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	58	5	free	free	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	58	6	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	58	7	surviving	survive	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	58	8	6	6	CD
work_4jheoe6s5jbc5lxgowinku6jgi	58	9	months	month	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	58	10	from	from	IN
work_4jheoe6s5jbc5lxgowinku6jgi	58	11	HSCT	HSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	58	12	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	58	13	median	median	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	58	14	CD41	CD41	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	58	15	count	count	NN
work_4jheoe6s5jbc5lxgowinku6jgi	58	16	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	58	17	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	58	18	100	100	CD
work_4jheoe6s5jbc5lxgowinku6jgi	58	19	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	58	20	105	105	CD
work_4jheoe6s5jbc5lxgowinku6jgi	58	21	cells/	cells/	CD
work_4jheoe6s5jbc5lxgowinku6jgi	58	22	ml	ml	NN
work_4jheoe6s5jbc5lxgowinku6jgi	58	23	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	58	24	range	range	VB
work_4jheoe6s5jbc5lxgowinku6jgi	58	25	10	10	CD
work_4jheoe6s5jbc5lxgowinku6jgi	58	26	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	58	27	403	403	CD
work_4jheoe6s5jbc5lxgowinku6jgi	58	28	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	58	29	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	59	1	Eight	eight	CD
work_4jheoe6s5jbc5lxgowinku6jgi	59	2	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	59	3	25	25	CD
work_4jheoe6s5jbc5lxgowinku6jgi	59	4	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	59	5	32	32	CD
work_4jheoe6s5jbc5lxgowinku6jgi	59	6	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	59	7	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	59	8	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	59	9	relapsed	relapse	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	59	10	after	after	IN
work_4jheoe6s5jbc5lxgowinku6jgi	59	11	HSCT	HSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	59	12	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	60	1	Probability	probability	NN
work_4jheoe6s5jbc5lxgowinku6jgi	60	2	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	60	3	survival	survival	NN
work_4jheoe6s5jbc5lxgowinku6jgi	60	4	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	60	5	OS	OS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	60	6	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	60	7	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	60	8	1	1	CD
work_4jheoe6s5jbc5lxgowinku6jgi	60	9	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	60	10	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	60	11	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	60	12	post	post	NN
work_4jheoe6s5jbc5lxgowinku6jgi	60	13	transplant	transplant	NN
work_4jheoe6s5jbc5lxgowinku6jgi	60	14	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	60	15	52	52	CD
work_4jheoe6s5jbc5lxgowinku6jgi	60	16	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	60	17	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	60	18	48	48	CD
work_4jheoe6s5jbc5lxgowinku6jgi	60	19	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	60	20	respectively	respectively	RB
work_4jheoe6s5jbc5lxgowinku6jgi	60	21	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	61	1	All	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	61	2	surviving	survive	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	61	3	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	61	4	are	be	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	61	5	disease	disease	NN
work_4jheoe6s5jbc5lxgowinku6jgi	61	6	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	61	7	free	free	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	61	8	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	62	1	OS	OS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	62	2	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	62	3	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	62	4	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	62	5	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	62	6	75	75	CD
work_4jheoe6s5jbc5lxgowinku6jgi	62	7	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	62	8	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	62	9	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	62	10	transplanted	transplant	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	62	11	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	62	12	CR	CR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	62	13	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	62	14	but	but	CC
work_4jheoe6s5jbc5lxgowinku6jgi	62	15	only	only	RB
work_4jheoe6s5jbc5lxgowinku6jgi	62	16	27	27	CD
work_4jheoe6s5jbc5lxgowinku6jgi	62	17	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	62	18	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	62	19	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	62	20	transplanted	transplant	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	62	21	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	62	22	active	active	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	62	23	disease	disease	NN
work_4jheoe6s5jbc5lxgowinku6jgi	62	24	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	63	1	KIR	KIR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	63	2	mismatching	mismatching	NN
work_4jheoe6s5jbc5lxgowinku6jgi	63	3	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	63	4	not	not	RB
work_4jheoe6s5jbc5lxgowinku6jgi	63	5	correlated	correlate	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	63	6	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	63	7	relapserates	relapserate	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	63	8	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	64	1	Incontrast	incontrast	NN
work_4jheoe6s5jbc5lxgowinku6jgi	64	2	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	64	3	child	child	NN
work_4jheoe6s5jbc5lxgowinku6jgi	64	4	tomother	tomother	NN
work_4jheoe6s5jbc5lxgowinku6jgi	64	5	transplants	transplant	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	64	6	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	64	7	AML	AML	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	64	8	ap-	ap-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	64	9	pear	pear	NN
work_4jheoe6s5jbc5lxgowinku6jgi	64	10	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	64	11	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	64	12	relapsing	relapse	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	64	13	at	at	IN
work_4jheoe6s5jbc5lxgowinku6jgi	64	14	higher	high	JJR
work_4jheoe6s5jbc5lxgowinku6jgi	64	15	rates	rate	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	64	16	than	than	IN
work_4jheoe6s5jbc5lxgowinku6jgi	64	17	other	other	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	64	18	combinations	combination	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	64	19	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	64	20	66	66	CD
work_4jheoe6s5jbc5lxgowinku6jgi	64	21	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	64	22	vs	vs	IN
work_4jheoe6s5jbc5lxgowinku6jgi	64	23	14	14	CD
work_4jheoe6s5jbc5lxgowinku6jgi	64	24	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	64	25	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	64	26	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	65	1	In	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	65	2	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	65	3	context	context	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	4	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	65	5	CY	CY	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	6	tolerization	tolerization	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	7	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	65	8	a	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	65	9	dose	dose	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	10	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	65	11	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	65	12	�	�	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	13	10e8	10e8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	65	14	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	65	15	kg	kg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	16	T	T	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	17	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	65	18	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	65	19	resultedinconsistentengraftment	resultedinconsistentengraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	20	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	65	21	prompt	prompt	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	65	22	immunereconstitution	immunereconstitution	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	23	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	65	24	lit-	lit-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	25	tle	tle	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	26	severe	severe	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	27	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	28	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	65	29	acceptable	acceptable	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	65	30	toxicity	toxicity	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	31	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	65	32	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	65	33	encouraging	encourage	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	65	34	overall	overall	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	65	35	sur-	sur-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	36	vival	vival	NN
work_4jheoe6s5jbc5lxgowinku6jgi	65	37	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	65	38	particularly	particularly	RB
work_4jheoe6s5jbc5lxgowinku6jgi	65	39	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	65	40	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	65	41	transplanted	transplant	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	65	42	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	65	43	CR	CR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	65	44	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	66	1	Using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	66	2	this	this	DT
work_4jheoe6s5jbc5lxgowinku6jgi	66	3	2-step	2-step	CD
work_4jheoe6s5jbc5lxgowinku6jgi	66	4	platform	platform	NN
work_4jheoe6s5jbc5lxgowinku6jgi	66	5	allows	allow	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	66	6	us	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	66	7	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	66	8	explore	explore	VB
work_4jheoe6s5jbc5lxgowinku6jgi	66	9	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	66	10	use	use	NN
work_4jheoe6s5jbc5lxgowinku6jgi	66	11	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	66	12	alternate	alternate	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	66	13	agents	agent	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	66	14	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	66	15	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	66	16	elimi-	elimi-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	66	17	nationofalloreactive	nationofalloreactive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	66	18	lymphocytes	lymphocyte	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	66	19	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	66	20	increase	increase	VB
work_4jheoe6s5jbc5lxgowinku6jgi	66	21	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	66	22	lengthoftime	lengthoftime	NN
work_4jheoe6s5jbc5lxgowinku6jgi	66	23	between	between	IN
work_4jheoe6s5jbc5lxgowinku6jgi	66	24	DLIand	DLIand	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	66	25	CY	CY	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	66	26	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	66	27	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	66	28	toemploytwo	toemploytwo	VB
work_4jheoe6s5jbc5lxgowinku6jgi	66	29	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	66	30	strategies	strategy	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	66	31	toimprove	toimprove	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	66	32	outcomes	outcome	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	66	33	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	66	34	high	high	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	66	35	risk	risk	NN
work_4jheoe6s5jbc5lxgowinku6jgi	66	36	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	66	37	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	67	1	53	53	CD
work_4jheoe6s5jbc5lxgowinku6jgi	67	2	UNMANIPULATED	UNMANIPULATED	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	3	HAPLOIDENTICAL	haploidentical	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	4	STEM	stem	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	5	CELL	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	6	TRANSPLANTATION	transplantation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	7	USING	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	67	8	MYELOABLATIVE	myeloablative	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	9	OR	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	67	10	REDUCED	reduced	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	11	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	67	12	INTENSITY	intensity	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	13	PRECONDITIONING	preconditioning	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	14	REGIMEN	REGIMEN	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	15	Ikegame	Ikegame	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	16	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	17	K.	K.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	18	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	19	Yoshihara	Yoshihara	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	20	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	21	S.	S.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	22	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	23	Kaida	Kaida	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	24	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	25	K.	K.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	26	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	27	Taniguchi	Taniguchi	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	28	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	29	K.	K.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	30	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	31	Inoue	Inoue	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	32	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	33	T.	T.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	34	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	35	Kato	Kato	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	36	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	37	R.	R.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	38	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	39	Fujioka	Fujioka	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	40	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	41	T.	T.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	42	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	43	Tamaki	Tamaki	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	44	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	45	H.	H.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	46	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	47	Okada	Okada	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	48	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	49	M.	M.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	50	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	51	Soma	Soma	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	52	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	53	T.	T.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	54	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	55	Taniguchi	Taniguchi	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	56	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	57	Y.	Y.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	58	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	59	Ogawa	Ogawa	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	60	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	61	H.	H.	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	62	Hyogo	Hyogo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	63	College	College	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	64	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	67	65	Medicine	Medicine	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	66	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	67	Nishinomiya	Nishinomiya	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	68	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	69	Hyogo	Hyogo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	70	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	71	Japan	Japan	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	72	Background	Background	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	73	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	67	74	Related	related	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	67	75	haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	67	76	donors	donor	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	67	77	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	78	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	67	79	cord	cord	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	80	blood	blood	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	81	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	67	82	can	can	MD
work_4jheoe6s5jbc5lxgowinku6jgi	67	83	be	be	VB
work_4jheoe6s5jbc5lxgowinku6jgi	67	84	alternative	alternative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	67	85	donor	donor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	86	sources	source	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	67	87	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	67	88	stem	stem	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	89	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	90	transplantation	transplantation	NN
work_4jheoe6s5jbc5lxgowinku6jgi	67	91	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	67	92	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	67	93	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	67	94	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	68	1	Severe	severe	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	68	2	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	68	3	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	68	4	however	however	RB
work_4jheoe6s5jbc5lxgowinku6jgi	68	5	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	68	6	has	have	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	68	7	interfered	interfere	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	68	8	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	68	9	progress	progress	NN
work_4jheoe6s5jbc5lxgowinku6jgi	68	10	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	68	11	haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	68	12	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	68	13	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	68	14	haploSCT	haploSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	68	15	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	68	16	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	69	1	To	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	69	2	deal	deal	VB
work_4jheoe6s5jbc5lxgowinku6jgi	69	3	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	69	4	this	this	DT
work_4jheoe6s5jbc5lxgowinku6jgi	69	5	strong	strong	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	69	6	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	69	7	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	69	8	T	T	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	69	9	cell	cell	NN
work_4jheoe6s5jbc5lxgowinku6jgi	69	10	depletion	depletion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	69	11	has	have	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	69	12	usually	usually	RB
work_4jheoe6s5jbc5lxgowinku6jgi	69	13	been	be	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	69	14	used	use	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	69	15	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	69	16	US	US	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	69	17	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	69	18	European	european	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	69	19	countries	country	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	69	20	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	70	1	In	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	70	2	order	order	NN
work_4jheoe6s5jbc5lxgowinku6jgi	70	3	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	70	4	pursue	pursue	VB
work_4jheoe6s5jbc5lxgowinku6jgi	70	5	the	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	70	6	controllable	controllable	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	70	7	GVL	GVL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	70	8	effect	effect	NN
work_4jheoe6s5jbc5lxgowinku6jgi	70	9	by	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	70	10	T	t	NN
work_4jheoe6s5jbc5lxgowinku6jgi	70	11	cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	70	12	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	70	13	we	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	70	14	have	have	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	70	15	performed	perform	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	70	16	unmanip-	unmanip-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	70	17	ulated	ulated	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	70	18	haploSCT	haploSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	70	19	using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	70	20	myeloablative	myeloablative	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	70	21	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	70	22	reduced	reduced	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	70	23	intensity	intensity	NN
work_4jheoe6s5jbc5lxgowinku6jgi	70	24	precondi-	precondi-	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	70	25	tioning	tione	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	70	26	regimen	regimen	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	70	27	accompanied	accompany	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	70	28	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	70	29	intensified	intensify	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	70	30	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	70	31	prophylaxis	prophylaxis	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	70	32	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	71	1	In	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	71	2	this	this	DT
work_4jheoe6s5jbc5lxgowinku6jgi	71	3	meeting	meeting	NN
work_4jheoe6s5jbc5lxgowinku6jgi	71	4	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	71	5	we	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	71	6	will	will	MD
work_4jheoe6s5jbc5lxgowinku6jgi	71	7	summarize	summarize	VB
work_4jheoe6s5jbc5lxgowinku6jgi	71	8	our	-PRON-	PRP$
work_4jheoe6s5jbc5lxgowinku6jgi	71	9	experience	experience	NN
work_4jheoe6s5jbc5lxgowinku6jgi	71	10	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	71	11	haploSCT	haploSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	71	12	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	71	13	more	more	JJR
work_4jheoe6s5jbc5lxgowinku6jgi	71	14	than	than	IN
work_4jheoe6s5jbc5lxgowinku6jgi	71	15	ten	ten	CD
work_4jheoe6s5jbc5lxgowinku6jgi	71	16	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	71	17	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	72	1	Patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	72	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	72	3	From	from	IN
work_4jheoe6s5jbc5lxgowinku6jgi	72	4	August	August	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	72	5	1998	1998	CD
work_4jheoe6s5jbc5lxgowinku6jgi	72	6	to	to	IN
work_4jheoe6s5jbc5lxgowinku6jgi	72	7	September	September	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	72	8	2010	2010	CD
work_4jheoe6s5jbc5lxgowinku6jgi	72	9	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	72	10	we	-PRON-	PRP
work_4jheoe6s5jbc5lxgowinku6jgi	72	11	have	have	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	72	12	performed	perform	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	72	13	351	351	CD
work_4jheoe6s5jbc5lxgowinku6jgi	72	14	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	72	15	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	72	16	haploSCT	haploSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	72	17	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	72	18	all	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	72	19	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	72	20	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	72	21	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	72	22	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	72	23	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	72	24	3	3	CD
work_4jheoe6s5jbc5lxgowinku6jgi	72	25	antigen	antigen	NN
work_4jheoe6s5jbc5lxgowinku6jgi	72	26	mismatched	mismatch	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	72	27	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	72	28	GVH	GVH	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	72	29	direction	direction	NN
work_4jheoe6s5jbc5lxgowinku6jgi	72	30	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	72	31	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	73	1	Patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	73	2	’	’	POS
work_4jheoe6s5jbc5lxgowinku6jgi	73	3	characteristics	characteristic	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	73	4	are	be	VBP
work_4jheoe6s5jbc5lxgowinku6jgi	73	5	sex	sex	NN
work_4jheoe6s5jbc5lxgowinku6jgi	73	6	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	73	7	male	male	NN
work_4jheoe6s5jbc5lxgowinku6jgi	73	8	186	186	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	9	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	73	10	female	female	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	73	11	168	168	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	12	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	73	13	age	age	NN
work_4jheoe6s5jbc5lxgowinku6jgi	73	14	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	73	15	16	16	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	16	-	-	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	73	17	65	65	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	18	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	73	19	old	old	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	73	20	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	73	21	median	median	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	73	22	39	39	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	23	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	73	24	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	73	25	disease	disease	NN
work_4jheoe6s5jbc5lxgowinku6jgi	73	26	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	73	27	AML	AML	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	73	28	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	73	29	MDS	MDS	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	73	30	149	149	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	31	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	73	32	ALL	all	DT
work_4jheoe6s5jbc5lxgowinku6jgi	73	33	81	81	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	34	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	73	35	ML	ML	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	73	36	67	67	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	37	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	73	38	others	other	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	73	39	54	54	CD
work_4jheoe6s5jbc5lxgowinku6jgi	73	40	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	74	1	83	83	CD
work_4jheoe6s5jbc5lxgowinku6jgi	74	2	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	74	3	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	74	4	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	74	5	underwent	undergo	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	74	6	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	74	7	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	74	8	non	non	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	74	9	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	74	10	complete	complete	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	74	11	remission	remission	NN
work_4jheoe6s5jbc5lxgowinku6jgi	74	12	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	74	13	non	non	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	74	14	-	-	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	74	15	CR	cr	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	74	16	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	74	17	state	state	NN
work_4jheoe6s5jbc5lxgowinku6jgi	74	18	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	75	1	Patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	75	2	under	under	IN
work_4jheoe6s5jbc5lxgowinku6jgi	75	3	45	45	CD
work_4jheoe6s5jbc5lxgowinku6jgi	75	4	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	75	5	old	old	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	75	6	underwent	undergo	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	75	7	mye-	mye-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	8	loablative	loablative	VB
work_4jheoe6s5jbc5lxgowinku6jgi	75	9	preconditioning	precondition	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	75	10	regimen	regiman	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	75	11	consisting	consist	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	75	12	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	75	13	FLU	FLU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	14	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	75	15	CA	CA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	16	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	75	17	CY/	CY/	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	18	TBI8Gy	tbi8gy	NN
work_4jheoe6s5jbc5lxgowinku6jgi	75	19	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	75	20	haplo	haplo	NN
work_4jheoe6s5jbc5lxgowinku6jgi	75	21	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	75	22	full	full	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	75	23	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	75	24	n	n	CC
work_4jheoe6s5jbc5lxgowinku6jgi	75	25	5	5	CD
work_4jheoe6s5jbc5lxgowinku6jgi	75	26	100	100	CD
work_4jheoe6s5jbc5lxgowinku6jgi	75	27	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	75	28	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	75	29	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	75	30	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	75	31	over	over	IN
work_4jheoe6s5jbc5lxgowinku6jgi	75	32	45	45	CD
work_4jheoe6s5jbc5lxgowinku6jgi	75	33	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	75	34	old	old	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	75	35	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	75	36	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	75	37	comorbidities	comorbiditie	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	75	38	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	75	39	repetitive	repetitive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	75	40	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	41	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	75	42	including	include	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	75	43	second	second	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	75	44	to	to	IN
work_4jheoe6s5jbc5lxgowinku6jgi	75	45	fifth	fifth	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	75	46	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	47	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	75	48	underwent	undergo	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	75	49	reduced	reduce	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	75	50	intensity	intensity	NN
work_4jheoe6s5jbc5lxgowinku6jgi	75	51	preconditioning	precondition	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	75	52	regimen	regiman	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	75	53	consist-	consist-	XX
work_4jheoe6s5jbc5lxgowinku6jgi	75	54	ing	ing	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	55	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	75	56	FLU/(CA)/BU	FLU/(CA)/BU	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	57	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	75	58	ATG	ATG	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	59	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	75	60	FLU/(CA)/MEL	FLU/(CA)/MEL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	61	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	75	62	ATG	ATG	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	63	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	75	64	haplo	haplo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	65	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	75	66	mini	mini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	75	67	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	75	68	n	n	CC
work_4jheoe6s5jbc5lxgowinku6jgi	75	69	5	5	CD
work_4jheoe6s5jbc5lxgowinku6jgi	75	70	251	251	CD
work_4jheoe6s5jbc5lxgowinku6jgi	75	71	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	75	72	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	76	1	High	high	RB
work_4jheoe6s5jbc5lxgowinku6jgi	76	2	dose	dose	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	76	3	Ara	Ara	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	76	4	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	76	5	C	C	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	76	6	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	76	7	CA	CA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	76	8	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	76	9	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	76	10	optional	optional	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	76	11	to	to	TO
work_4jheoe6s5jbc5lxgowinku6jgi	76	12	reduce	reduce	VB
work_4jheoe6s5jbc5lxgowinku6jgi	76	13	tumor	tumor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	76	14	burden	burden	NN
work_4jheoe6s5jbc5lxgowinku6jgi	76	15	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	77	1	As	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	77	2	ATG	ATG	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	77	3	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	77	4	ATG	ATG	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	77	5	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	77	6	Fresenius	Fresenius	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	77	7	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	77	8	8mg	8mg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	77	9	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	77	10	kg	kg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	77	11	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	77	12	or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	77	13	thymoglubulin	thymoglubulin	NN
work_4jheoe6s5jbc5lxgowinku6jgi	77	14	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	77	15	genzyme	genzyme	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	77	16	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	77	17	2-	2-	LS
work_4jheoe6s5jbc5lxgowinku6jgi	77	18	4mg	4mg	NN
work_4jheoe6s5jbc5lxgowinku6jgi	77	19	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	77	20	kg	kg	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	77	21	were	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	77	22	used	use	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	77	23	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	78	1	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	2	prophylaxis	prophylaxi	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	78	3	consisted	consist	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	78	4	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	78	5	taclolimus	taclolimus	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	6	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	78	7	TAC	TAC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	8	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	78	9	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	78	10	methylprednisolone	methylprednisolone	NN
work_4jheoe6s5jbc5lxgowinku6jgi	78	11	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	78	12	mPSL	mPSL	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	13	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	78	14	2mg	2mg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	15	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	78	16	kg	kg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	17	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	78	18	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	78	19	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	78	20	short	short	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	78	21	term	term	NN
work_4jheoe6s5jbc5lxgowinku6jgi	78	22	MTX	MTX	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	23	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	78	24	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	78	25	mycophenolate	mycophenolate	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	26	mofetil	mofetil	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	27	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	78	28	MMF	MMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	29	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	78	30	15mg	15mg	NN
work_4jheoe6s5jbc5lxgowinku6jgi	78	31	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	78	32	kg	kg	NN
work_4jheoe6s5jbc5lxgowinku6jgi	78	33	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	78	34	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	78	35	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	78	36	haplo	haplo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	37	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	78	38	full	full	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	78	39	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	78	40	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	78	41	TAC	TAC	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	42	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	78	43	mPSL	mpsl	CD
work_4jheoe6s5jbc5lxgowinku6jgi	78	44	1mg	1mg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	45	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	78	46	kg	kg	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	47	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	78	48	day	day	NN
work_4jheoe6s5jbc5lxgowinku6jgi	78	49	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	78	50	haplo	haplo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	51	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	78	52	mini	mini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	78	53	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	78	54	respectively	respectively	RB
work_4jheoe6s5jbc5lxgowinku6jgi	78	55	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	79	1	For	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	79	2	elderly	elderly	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	79	3	pa-	pa-	NN
work_4jheoe6s5jbc5lxgowinku6jgi	79	4	tients	tient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	79	5	over	over	IN
work_4jheoe6s5jbc5lxgowinku6jgi	79	6	50	50	CD
work_4jheoe6s5jbc5lxgowinku6jgi	79	7	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	79	8	old	old	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	79	9	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	79	10	haplo	haplo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	79	11	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	79	12	mini	mini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	79	13	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	79	14	MMF	MMF	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	79	15	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	79	16	added	add	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	79	17	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	80	1	Results	result	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	80	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	80	3	Hematopoietic	hematopoietic	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	80	4	engraftment	engraftment	NN
work_4jheoe6s5jbc5lxgowinku6jgi	80	5	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	80	6	haploSCT	haploSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	80	7	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	80	8	as	as	RB
work_4jheoe6s5jbc5lxgowinku6jgi	80	9	rapid	rapid	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	80	10	as	as	IN
work_4jheoe6s5jbc5lxgowinku6jgi	80	11	that	that	DT
work_4jheoe6s5jbc5lxgowinku6jgi	80	12	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	80	13	HLA	HLA	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	80	14	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	80	15	identical	identical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	80	16	SCT	SCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	80	17	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	80	18	except	except	IN
work_4jheoe6s5jbc5lxgowinku6jgi	80	19	ten	ten	CD
work_4jheoe6s5jbc5lxgowinku6jgi	80	20	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	80	21	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	80	22	graft	graft	NN
work_4jheoe6s5jbc5lxgowinku6jgi	80	23	rejection	rejection	NN
work_4jheoe6s5jbc5lxgowinku6jgi	80	24	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	81	1	Acute	acute	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	81	2	GVHD	GVHD	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	81	3	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	81	4	grade	grade	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	81	5	II	II	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	81	6	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	81	7	IV	IV	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	81	8	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	81	9	was	be	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	81	10	observed	observe	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	81	11	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	81	12	30	30	CD
work_4jheoe6s5jbc5lxgowinku6jgi	81	13	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	81	14	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	82	1	Overall	overall	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	82	2	survival	survival	NN
work_4jheoe6s5jbc5lxgowinku6jgi	82	3	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	82	4	five	five	CD
work_4jheoe6s5jbc5lxgowinku6jgi	82	5	years	year	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	82	6	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	82	7	30	30	CD
work_4jheoe6s5jbc5lxgowinku6jgi	82	8	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	82	9	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	82	10	haplo	haplo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	82	11	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	82	12	full	full	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	82	13	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	82	14	40	40	CD
work_4jheoe6s5jbc5lxgowinku6jgi	82	15	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	82	16	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	82	17	haplo	haplo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	82	18	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	82	19	mini	mini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	82	20	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	82	21	respectively	respectively	RB
work_4jheoe6s5jbc5lxgowinku6jgi	82	22	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	83	1	If	if	IN
work_4jheoe6s5jbc5lxgowinku6jgi	83	2	limited	limit	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	83	3	to	to	IN
work_4jheoe6s5jbc5lxgowinku6jgi	83	4	CR	CR	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	83	5	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	83	6	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	83	7	overall	overall	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	83	8	survival	survival	NN
work_4jheoe6s5jbc5lxgowinku6jgi	83	9	reached	reach	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	83	10	over	over	IN
work_4jheoe6s5jbc5lxgowinku6jgi	83	11	60	60	CD
work_4jheoe6s5jbc5lxgowinku6jgi	83	12	%	%	NN
work_4jheoe6s5jbc5lxgowinku6jgi	83	13	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	83	14	haplo-	haplo-	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	83	15	mini	mini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	83	16	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	84	1	There	there	EX
work_4jheoe6s5jbc5lxgowinku6jgi	84	2	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	84	3	no	no	DT
work_4jheoe6s5jbc5lxgowinku6jgi	84	4	difference	difference	NN
work_4jheoe6s5jbc5lxgowinku6jgi	84	5	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	84	6	survival	survival	NN
work_4jheoe6s5jbc5lxgowinku6jgi	84	7	rate	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	84	8	among	among	IN
work_4jheoe6s5jbc5lxgowinku6jgi	84	9	patients	patient	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	84	10	’	’	POS
work_4jheoe6s5jbc5lxgowinku6jgi	84	11	diseases	disease	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	84	12	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	85	1	Discussion	discussion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	85	2	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	85	3	Unmanipulated	Unmanipulated	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	85	4	haploSCT	haploSCT	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	85	5	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	85	6	feasible	feasible	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	85	7	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	85	8	effective	effective	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	85	9	for	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	85	10	refractory	refractory	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	85	11	diseases	disease	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	85	12	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	86	1	ATG	ATG	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	86	2	dose	dose	VBD
work_4jheoe6s5jbc5lxgowinku6jgi	86	3	used	use	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	86	4	in	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	86	5	haplo	haplo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	86	6	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	86	7	mini	mini	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	86	8	is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	86	9	critical	critical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	86	10	,	,	,
work_4jheoe6s5jbc5lxgowinku6jgi	86	11	and	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	86	12	rather	rather	RB
work_4jheoe6s5jbc5lxgowinku6jgi	86	13	low	low	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	86	14	compared	compare	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	86	15	with	with	IN
work_4jheoe6s5jbc5lxgowinku6jgi	86	16	that	that	DT
work_4jheoe6s5jbc5lxgowinku6jgi	86	17	of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	86	18	European	european	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	86	19	cases	case	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	86	20	reported	report	VBN
work_4jheoe6s5jbc5lxgowinku6jgi	86	21	so	so	RB
work_4jheoe6s5jbc5lxgowinku6jgi	86	22	far	far	RB
work_4jheoe6s5jbc5lxgowinku6jgi	86	23	.	.	.
work_4jheoe6s5jbc5lxgowinku6jgi	87	1	Cord	Cord	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	2	Blood	blood	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	3	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	87	4	Cb	Cb	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	5	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	87	6	Apgar	Apgar	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	7	Score	Score	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	8	Is	be	VBZ
work_4jheoe6s5jbc5lxgowinku6jgi	87	9	Predictive	predictive	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	87	10	Of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	11	Neutrophil	Neutrophil	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	12	Engraftment	Engraftment	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	13	And	and	CC
work_4jheoe6s5jbc5lxgowinku6jgi	87	14	Graft	Graft	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	15	Failure	Failure	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	16	Probabilities	Probabilities	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	17	For	for	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	18	Plasma	Plasma	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	19	Depleted	Depleted	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	20	/	/	SYM
work_4jheoe6s5jbc5lxgowinku6jgi	87	21	Red	Red	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	22	...	...	.
work_4jheoe6s5jbc5lxgowinku6jgi	87	23	In	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	24	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	87	25	Vivo	Vivo	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	26	Expansion	expansion	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	27	Of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	28	T	t	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	29	Regulatory	regulatory	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	87	30	Cells	cell	NNS
work_4jheoe6s5jbc5lxgowinku6jgi	87	31	By	by	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	32	Rapamycin	Rapamycin	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	33	In	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	34	A	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	87	35	Calcineurin	Calcineurin	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	36	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	87	37	Inhibitor	inhibitor	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	38	Free	Free	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	39	Gvhd	Gvhd	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	40	Prophylaxis	Prophylaxis	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	41	In	in	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	42	Unmanipulated	Unmanipulated	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	43	Hapl	Hapl	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	44	...	...	NFP
work_4jheoe6s5jbc5lxgowinku6jgi	87	45	8/8	8/8	CD
work_4jheoe6s5jbc5lxgowinku6jgi	87	46	High	high	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	87	47	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	87	48	Resolution	resolution	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	49	Hla	Hla	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	50	Match	Match	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	51	Rate	rate	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	52	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	87	53	The	the	DT
work_4jheoe6s5jbc5lxgowinku6jgi	87	54	Impact	Impact	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	55	Of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	56	Race	Race	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	57	A	a	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	58	2	2	CD
work_4jheoe6s5jbc5lxgowinku6jgi	87	59	Step	step	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	60	Approach	approach	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	61	To	to	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	62	Myeloablative	Myeloablative	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	63	Haploidentical	haploidentical	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	87	64	Hematopoietic	Hematopoietic	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	65	Stem	Stem	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	66	Cell	Cell	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	67	Transplanation	Transplanation	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	68	(	(	-LRB-
work_4jheoe6s5jbc5lxgowinku6jgi	87	69	Hsct	Hsct	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	70	)	)	-RRB-
work_4jheoe6s5jbc5lxgowinku6jgi	87	71	:	:	:
work_4jheoe6s5jbc5lxgowinku6jgi	87	72	Report	report	VB
work_4jheoe6s5jbc5lxgowinku6jgi	87	73	Of	of	IN
work_4jheoe6s5jbc5lxgowinku6jgi	87	74	A	a	DT
work_4jheoe6s5jbc5lxgowinku6jgi	87	75	Phase	Phase	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	76	Ii	Ii	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	77	Trial	trial	NN
work_4jheoe6s5jbc5lxgowinku6jgi	87	78	...	...	:
work_4jheoe6s5jbc5lxgowinku6jgi	87	79	Unmanipulated	Unmanipulated	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	80	Haploidentical	Haploidentical	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	81	Stem	Stem	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	82	Cell	Cell	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	83	Transplantation	Transplantation	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	84	Using	use	VBG
work_4jheoe6s5jbc5lxgowinku6jgi	87	85	Myeloablative	Myeloablative	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	86	Or	or	CC
work_4jheoe6s5jbc5lxgowinku6jgi	87	87	Reduced	reduced	JJ
work_4jheoe6s5jbc5lxgowinku6jgi	87	88	-	-	HYPH
work_4jheoe6s5jbc5lxgowinku6jgi	87	89	Intensity	Intensity	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	90	Preconditioning	Preconditioning	NNP
work_4jheoe6s5jbc5lxgowinku6jgi	87	91	Regimen	Regimen	NNP